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I. INTRODUCTION
Confusion concerning genetically modified (GM) foods has grown
over the past few years into a debate whether GM foods should be
labeled as such for the benefit of the consumer. The public has been
confronted with conflicting accounts of safety hazards from the
scientific community1 and consumer advocate groups2 that have resulted
I. Recently released studies by the National Academy of Sciences, the
Organization for Economic Cooperation and Development, and the Subcommittee on
Basic Research of the U.S. House of Representatives Committee on Science claim GM
foods are safe. See The Weight of the Evidence: Assessing the Safety of Biotech Foods,
FOOD INSIGHT (May-June 2000), available at http://ificinfo.health.org/insightl MayJune
00/weight.htm. Rejecting mandatory labeling for GM foods in May 2000, the Food and
Drug Administration stated: "scientific review continues to show that all bioengincered
foods sold here in the United States today are as safe as their non-bioengineered
counterparts." Press Release, Food and Drug Administration, FDA to Strengthen Pre-
Market Review of Bioengineered Foods, at http://www.fda.gov/bbs/ topics/NEWS/
NEW00726.html (May 3, 2000). In December 2000, the American Medical Association
recognized the continuing validity of such studies, encouraged further studies, and
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in a fear of biotechnology that must be addressed." Consumer advocate
groups have focused on mandatory labeling of GM foods as a solution to
calm consumer fears and protect mankind from potential safety risks.4
The scientific community and the regulatory authorities responsible for
maintaining food-labeling guidelines, however, have found that GM
foods pose no additional safety risk to consumers5 and have therefore
sought other solutions to manage public fears.
In May 2000, the debate reached a new height when the Food and
Drug Administration (FDA) announced that mandatory labeling is not an
appropriate way to deal with GM foods.6 The FDA has chosen instead
to establish a set of guidelines for voluntary labeling.7 In addition, the
FDA has decided to mandate that food producers and manufacturers
concluded that "[tihere is no scientific justification for special labeling of genetically
modified foods, as a class, and [that] voluntary labeling is without value unless it is
accompanied by focused consumer education." Genetically Modified Crops and Foods,
at http:llwww.ama-assn.orglamalpub/article/2036-3604.html (Dec. 14, 2000.
2. Activists including Greenpeace, the Sierra Club, the Organic Consumers
Association, the International Center for Technology Assessment, and others have
performed demonstrations to stop the use of GM crops for fear that there has not been
enough research to demonstrate safety at this time. See Lisa M. Krieger, Activists
Pressure Federal Officials to Label Genetically-Altered Foods, SAN JOSE MERCURY
NEVs, Dec. 14, 1999, 1999 WL 28717179. The International Center for Technology
Assessment filed suit against the FDA in February 1999 to contest the FDA's position
supporting the safety of GM foods. Id.; see also Alliance for Bio-lntegrity v. Shalala,
116 F. Supp. 2d 166 (D.D.C. 2000), discussed infra Parts LI.B, IV.A.3.
3. For a general discussion of the debate, see Mark Mansour & Jennifer B.
Bennett, Dispute Over Modified Food Hits U.S., NAT'L LJ., Nov. 29, 1999, at B 11. For
a pro-GM view, see Elizabeth Whelan, The Case for Genetically Modified Food, at
http://www.nutrinews.comlpublic/homeindex.cfm (last visited July 28, 2001). For an
opposing view see Claire Robinson, The Case Against Genetically Engineered Food, tt
http://wv.nutrinews.com/public/home/index.cftn (last visited July 28, 2001).
4. See Mansour & Bennett, supra note 3, at B 11.
5. See supra text accompanying note 1.
6. FDA announced a plan rejecting mandatory labeling, but requiring "developers
of bioengineered foods and animal feeds [to] notify the agency w hen they intend to
market such products." See Press Release, FDA to Strengthen Pre-Market Review of
Bioengineered Foods, at http://www.fda.gov/bbs/topics/NEWS/NEW00726.htmil (IMay
3, 2000). The proposed solution requires notification at least 120 days prior to
marketing. Id. The FDA vill review information submitted and release this information
to consumers via its Web site. Id. The FDA released a detailed report of its new year-
2000 GM food policy and proposed regulations in January 2001. See Premarket Notice
Concerning Bioengineered Foods, 66 Fed. Reg. 4706 (proposed Jan. 18, 2001) (to be
codified at 21 C.F.R. pts. 192 & 592). The FDA also released guidelines for voluntary
labeling of GM foods. See Draft Guidance for Industry: Voluntary Labeling Indicating
Whether Foods Have or Have Not Been Developed Using Bioengineering; Availability,
66 Fed. Reg. 4839 (Jan. 18, 2001).
7. See supra text accompanying note 6.
consult with the FDA concerning new GM foods before introducing
8them to the market. This decision to require mandatory safety testing
and approval of GM foods instead of mandatory labeling, while one of
the first resolutions in the debate over GM foods, will not be the final
word.
Consumer advocacy groups will, no doubt, fight the decision made by
the FDA not to mandate labeling of GM foods. The focus of these
efforts will be on rising consumer fears and the consumer's right to
know.9 The first lawsuit challenging the FDA's decision not to mandate
labeling was recently dismissed." Congress has yet to address several
bills that would require, for example, mandatory labeling of GM foods" or
mandatory testing and product consultation procedures12 due to the
recent FDA action. More important, and more likely to extend the
debate, are several state bills proposed to mandate labeling
t3 or take
alternate action against GM food products on the state level.'
8. Id. Prior to this decision, the FDA reviewed new GM foods through a
voluntary consultation process. See Statement of Policy: Foods Derived from New Plant
Varieties, 57 Fed. Reg. 22,984, 22,988-89 (May 29, 1992). The FDA relied on the legal
duty of food producers to ensure product safety established under the FDA guidelines for
adulterated foods (foods that contain added poisonous substances). Id. at 22,988.
9. In response to the FDA's announcement of a voluntary, as opposed to a
mandatory labeling policy, proponents of mandatory labeling openly denounced the
decision saying that "voluntary labeling means no labeling at all," and that the FDA has
turned the United States into a country of "guinea pigs." Mike Pezzella, GM Food
Regulations Aim to Avoid Euro-Style Frankenfood Panic, BIOTECHNOLOGY NEWSWATCH,
May 15, 2000, at 1, 2000 WL 7388302; see also Anita Manning, FDA Plans to Serve
Data Before Biotech Food, but Critics Say Labeling Is Needed, USA TODAY, May 4,
2000, at I ID, 2000 WL 5777274. The reaction was the same in January 2001 when the
FDA released its updated GM food policy rejecting mandatory labeling. See Marc
Kaufman, FDA Issues Biotech Food Rules: Proposals Address Labeling, Advance Notice
of New Products, WAsH. PosT, Jan. 18, 2001, at E3 (noting that opponents of GM have
called the recent FDA policy "misguided").
10. See Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166 (D.D.C. 2000)
(discussed infra Parts Il.B, IV.A.3).
11. See H.R. 3377, 106th Cong. (1999), WL 1999 CONG US HR 3377. Several
other GM related bills introduced in 2000 and 2001 will also be reviewed. See S. 2080,
106th Cong. (2000); S. 2315, 106th Cong. (2000); H.R. 115, 107th Cong. (2001); H.R.
2343, 107th Cong. (2001); H.R. 713, 107th Cong. (2001).
12. See S. 3184, 106th Cong. (2000), WL 1999 CONG US S 3184.
13. See H.R. 5395, 90th Leg. (Mich. 2000), WL 1999 MI H.B. 5395; H. 5399,
90th Leg. (Mich. 2000), WL 1999 MI H.B. 5399; H.R. 3973, 81st Sess. (Minn. 2000),
WL 1999 MN H.F. 3973; H.R. 453, 184th Gen. Assemb. (Pa. 2000), WL 1999 PA H.R.
453; S. 1513, 1999-2000 Reg. Sess. (Cal. 2000); H.R. 794, 1999-2000 Sess. (Vt. 2000),
WL 1999 VT H.B. 794; S. 295, 1999-2000 Sess. (Vt. 2000), 1999 VT S.B. 295.
14. California has reviewed legislative guidelines designed to protect the "parents'
right-to-know" whether their children eat GM products in public schools. S. 1514,
1999-2000 Reg. Sess. (Cal. 2000). California also recently passed a bill establishing a
rice certification program designed to monitor "characteristics of commercial impact"
which include those characteristics that cannot be identified without special testing in
order to avoid commingling of rice varieties. CAL. FOOD & AGRIC. CODE §§ 55000-108
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Another important focus of the debate has centered around foreign
policies that mandate labeling of certain GM foods and the potential
interference such policies will pose on world trade due to the United
States' decision not to follow suit.'5 While many attempts have been
made to develop a uniform international policy, little progress has
occurred in this area.16 With the recent stance taken by the FDA, the
United States government is likely to continue to advocate against
foreign anti-GM policies on the ground that they are not based on sound
scientific principles but rather on exaggerated consumer fears.
The GM food labeling debate must be settled soon. For the consumer
to reap the benefits of the powerful new genetic technologies designed
specifically to enhance food safety, nutrition, and supply, scientific
progress must no longer be obstructed or overrun by unfounded fears.
The labeling debate has already caused a few leading food suppliers to
publicly shy away from using genetically modified foods to avoid public
(Deering 1997 & Supp. 2001). New York is considering a "'moratorium on the planting
and growing" of GM crops for 5 years. Assemb. 9871, 223d sess. (N.Y. 2000). WiL
1999 NY A.B. 9871. Nebraska has before it bills that would create a state grain
certification program to verify that grain has not been genetically modified, and make
food suppliers liable if their GM crops "cross-pollinat[e]" neighboring non-GM crops.
Leg. 959, 96th Leg., 2d Reg. Sess. (Neb. 2000), WL 1999 NE L.B. 959. West Virginia
is considering a bill that would restrict GM food sales in public schools. S. 605, 75th
Leg. (,V. Va. 2000), WL 2000 WV S.B. 605. Iowa will review two bills, one of which
prohibits those that sell GM products from passing any charges associated with genetic
modifications along to the consumer. S. 2189,78th Gen. Assemb., 2d Sess. (lo,,a 2000),
WL 1999 IA S.F. 2189.
15. See Frederick H. Degnan, The Food Label and the Right-to-Know, 52 FOOD &
DRUG L.L 49, 56 (1997); A. Bryan Endres, "GMO:" Genetically Modified Org0aism or
Gigantic Monetary Obligation? The Liability Schemes for GMO Danmage in the United
States and the European Union, 22 LOy. L.A. INT'L & COMP. L REv. 453 (2000)- John
Stephen Fredland, Note, Unlabel Their Frankenstein Foods!: Evaluating it U.S.
Challenge to the European Coimnission's Labeling Requirements for Food Products
Containing Genetically-Modified Organisms, 33 VAND. J. TRANSNA'L L 183 (20001;
Terence P. Stewart & David S. Johanson, Policy in Fltr: The European Union's Lairs
on Agricultural Biotechnology and Their Effects on International Trade, 4 DRAKE J.
AGRIc. L. 243 (1999); Dennis T. Avery, Scrap Cap: EU Food Standards Are a Global
Health Hazard, WALL ST. J. EuR., July 5, 2000, at 6, 2000 WL-WSJE 21065536.
16. After several years of debate, the Codex Alimentarius Commission. a United
Nations group representing 167 countries, in attempting to settle the international debate
over labeling of GM foods, again postponed a decision on the matter in May 2000.
pending further study. See UN Group Stuck on Labeling of Genetically.Modified Foods.
Dow JONES INT'L NEws, May 10, 2000, WL, All News Plus Wires. For a general
overview of the Codex Alimentarius and its focus in regard to GM food labeling, see H.
Michael Wehr, Update on Issues Before the Coder Alimentarius. 52 FOOD & DRUG L.J.
531 (1997).
scrutiny.17 Even more importantly, due to the great difficulty and high
cost associated with developing new labeling procedures, the debate has
generated serious alarm for food suppliers, thereby causing technological
delays in certain areas.' 8  Faced with the nearly impossible task of
developing new procedures to establish whether GM foods are used in
its products, food producers have become weary of using GM
technologies in general. 19 Because GM foods are designed to avoid the
use of harmful chemical pesticides, to improve nutritional value, 20 and to
reduce world food supply shortages,2 ' settlement of the labeling issue
17. Frito-Lay, Gerber Products, and McDonalds have publicly announced efforts
to ban certain uses of GM food products. See David Barboza, Modified Foods Put
Companies in a Quandary, N.Y. TIMES, June 4, 2000, at Al. But see David Koenig,
PepsiCo Shareholders Reject Proposal to Stop Using Genetically Engineered Crops,
ASSOCIATED PRESS NEWSWIRES, May 3, 2000, WL 5/3/00 APWIRES 19:39:00.
18. Mandatory labeling initiatives tend to raise costs for manufacturers in several
areas. For instance, mandatory labeling would add costs to test products in order to
segregate those products that need labeling from those that do not. Also, such labeling
initiatives would require new labels to be designed and printed, new packaging for
products to be developed, and the establishment of new distribution chains. Total cost
increases due to mandatory labeling requirements could be as high as 1.4% of the
national cost of that product. W. Kip Viscusi, PRODUCT-RISK LABELING: A FEDERAL
RESPONSIBILITY 9 (1993). Food costs alone, if one out of every fourteen products
required new labeling in a sampling of five states, could reach as high as fifty million
dollars a year. Id. While costs are a large source of alarm for food suppliers, the biggest
concern over mandatory labeling of GM foods centers around the "impossib[ility] to
track the origin of ingredients in many food products" making it tremendously difficult
to determine which products would need to be labeled. Kim Severson, Food in the
News: California Says No to Biotech Food Labels, S.F. CHRON., May 10, 2000, Food
(Zone 6), at 7. Food suppliers are also worried that mandatory labeling will only give
consumers reason for unnecessary concern and result in decreases in product sales as
well. See Barboza, supra note 17, at Al. Requiring mandatory nutritional product
labeling in the early 1990s was estimated to cost over 100 million dollars. Food
Labeling; Declaration of Ingredients, 56 Fed. Reg. 28,592, 28,616 (June 21, 1991).
19. See supra note 18 and accompanying text.
20. Biotechnology has already been used to modify foods to provide disease
resistance, reduce the need for harmful pesticides, enhance the nutritional value of foods,
speed the growth process in several important crops, provide herbicide tolerance, and
improve general taste and quality of foods. For example, the following GM foods can be
found on the market today: corn, soybeans, and potatoes that do not require high doses of
herbicide or pesticide treatments; tomatoes and peppers with better flavor; soybeans with
lower saturated fat contents; and papayas that are resistant to threatening viruses. See
International Food Information Council Foundation, Background on Food Biotechnology, at
http://ific.org/food/biotechnology.vtmi (last visited July 27, 2001). See generally
MARTINA MCGLOUGHLIN, WHY SAFE AND EFFECTIVE FOOD BIOTECHNOLOGY IS IN THE
PUBLIC INTEREST (Wash. Legal Found, Critical Legal Issues Working Paper Series 99),
at http://www.wlf.org (Nov. 2000); Elizabeth Whelan, The Case for Genetically
Modified Food, at http://www.nutrinews.com/public/index.cfm (last visited July 28,
2001).
21. In a report released in the summer of 2000 by the World Academy of Sciences,
GM foods have been deemed "crucial to overcoming hunger for 800 million food-short
residents of poor countries and preventing the deaths of six million children under five
who currently die each year from malnutrition." Dennis T. Avery, Bountiful Harvest:
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must focus on fostering technological growth and not on increasing
consumer fears.
Recent studies have demonstrated that these consumer fears are real.
However, the studies have also demonstrated greater consumer support
than fear for GM foods.22 Statistics indicate that even the consumer
himself does not necessarily believe that the "right to know" should be
enforced through mandatory labeling and that the consumer is willing to
trust the FDA to make these important decisions.- These findings, in
combination with several recent scientific studies that find no safety risk
inherent in GM foods in general,24 demand a careful review of the
opposition's scientifically unsound and arguably flawed position on the
matter.
This Comment supports the FDA's recent stance rejecting mandatory
labeling as a solution to accommodate consumer fears. While the consumer's
right to know is an important ight to protect, it is not an absolute right.
The FDA has consistently recognized limitations on this right where no
apparent safety risk exists.2 For this reason, the FDA's decision is
Biotech Can Feed the World, WALL ST. J. EUR, July 28, 2000, at 8. 2000 \WL-WSJE
21067302. Golden rice, for example, is one of the first breakthroughs in biotechnology
designed specifically to assist the poorest countries in the world. See J. Madeline Nash.
Grains of Hope, TIMAE, July 31, 2000, at 38. The rice has been genetically designed to
provide vitamin A, an essential nutrient not normally provided in rice, to benefit over
one million children that die due to lack of the vitamin as well as more than 350,000 that
go blind as a result of vitamin A deficiencies. Id. "Despite fears of genetically altered
soybeans, corn and other crops, people will have to rely more and more on genetic
engineering and other advances in science and technology to feed the world," according
to U.S. Agriculture Secretary, Dan Glickman. David White, Give Biotech a Chance to
Feed World, Ag Chief Says, BIRMINGHAMi NEws, OcL 11, 2000, available at
www.bhamnews.com/archive.html. World Hunger has been identified as a more serious
concern than Global Warming or Pollution. See Americans Say Hunger More Urgent
World Problem Than Global IVanning and Pollution; More than Two-Thirds Support
the Use of Food and Agricultural Biotechnology as a Tool to Help Solve Problem, at
http://betterfoods. org/fft_10 00.htm (Oct. 12. 2000).
22. The International Food Information Counsel announced recent data on a
multiyear study designed to weigh changes in consumer attitudes related to GM foods
over time. See U.S. Consumer Attitudes Toward Food Biotechnology, at htp:ificinfo.
health. orglfoodbiotech/survey.htm (last visited July 14, 2000).
23. Id. For instance, 54% of those surveyed in May 2000 said they would be
likely to buy foods altered by biotechnology to "taste better and fresher" as compared to
43% that said they would not. Id. Likewise, 69% of those surveyed said they would
purchase modified foods designed to require "fewer pesticide applications" as compared
to only 28% that said they would not. Id. When asked whether they supported the FDA
in its labeling decisions, 52% said they did compared to 43% that said they did not. Id.
24. See supra text accompanying note 1.
25. See Fred H. Degnan, Biotechnology and the Food Label: A Legal Perspective.
consistent with its own policies and legal precedent.
Following this introduction, Part II of this Comment begins by
providing some background to the scientific and regulatory nature of the
GM food debate.26 Due to the dispute that is likely to center around the
FDA's recent decision, Part El of this Comment addresses the precedent
that supports the FDA's actions and demonstrates that the FDA has
acted appropriately under the circumstances. Part IV adopts and applies
a balancing approach designed to evaluate whether mandatory labeling
initiatives are appropriate to protect the consumer's right to know.
When weighing the rights of the food suppliers (i.e., those that would be
burdened with the task of labeling GM food products) against the
consumer's right to know, the FDA was warranted in finding mandatory
labeling an inappropriate solution for GM foods in general.
Because many states have already started exploring alternative forms
of legislation 27 to address consumer concerns, Part V focuses on the
need for individual states to follow the guidelines established by the
FDA and suggests that states apply the right to know balancing test
when evaluating pending bills and other proposed initiatives in this area.
Finally, Part VI establishes goals for addressing the GM food debate on
the state level. In addition, several possible solutions are provided that
focus on maintaining an appropriate balance between the supplier's
commercial rights and the consumer's right to know.
II. BACKGROUND
Much of the confusion over GM foods derives from a lack of public
education about the differences between traditional food processing
methodologies and modern genetic technologies. Most consumers do
55 FOOD & DRUG L.J. 301 (2000).
26. This Comment makes no attempt to settle all scientific disputes concerning
GM technologies. Rather, it seeks only to introduce the reader to those factors that led
the FDA to make its finding that GM food products in general do not pose particular
risks of harm. The FDA spent more than ten years listening to debate from opposing
points of view from the scientific community, consumer advocate organizations, industry
officials, and environmentalists before announcing its new policy in January 2001. See,
Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg. 22,984,
22,984 (May 29, 1992); Press Release, Food and Drug Administration, FDA to
Strengthen Pre-Market Review of Bioengineered Foods, at http://www.fda.gov/bbs/
topics/NEWS/NEW00726.html (May 3, 2000); Premarket Notice Concerning Bioenginecrcd
Foods, 66 Fed. Reg. 4706, 4707-08 (proposed Jan. 18, 2001) (to be codified at 21 C.F.R.
pts. 192 & 592); Draft Guidance for Industry: Voluntary Labeling Indicating Whether
Foods Have or Have Not Been Developed Using Bioengineering; Availability, 66 Fed.
Reg. 4839, 4839-40 (Jan. 18, 2001). For the purposes of this Comment, and the analysis
that follows, the scientific conclusions of the FDA are crucial to the validation of the
FDA's stance on the GM food labeling debate.
27. See supra notes 13-14.
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not realize that a majority of foods currently on grocery store shelves
were created using some form of genetic enhancement.' In fact, the
food industry has utilized genetic modification as a standard tool for
over one hundred years.29 Modem technologies are actually considered
safer and more efficient than the older methods employed" and should
therefore give less reason for concern. Following is a brief discussion of
the new technologies that are the source of consumer fear and how they
relate to those that have been used to modify food products for many
years. Also included is a discussion of the fears that GM opponents
raise and the precautionary principle. Finally, a list of the relevant
regulatory agencies involved in protecting consumer safety and the policies
used to determine how labeling regulations are established is provided.
A. Genetics in the Food Industr'
All foods contain genetic material,3' whether derived from plants or
animals. Inside every plant or animal cell lies its essential coding
material, DNA.32 Most people are familiar with the role of DNA in
heredity and the reproduction of a species.- But, DNA also encodes for
28. See hifra note 55.
29. According to FDA Commissioner, Jane E. Henney. M.D., "all crops have been
genetically modified through traditional plant breeding for more than a hundred years.
Larry Thompson, Are Bloengineered Foods Safe?, FDA CONSUMER (Jan.-Feb. 2000). at
http:llwww.fda.gov/fdaclfeaturesl2000/100_bio.html.
30. Traditional plant breeding has been deemed safe and "biotechnology can make
it safer." International Food Information Council Foundation, Background on Food
Biotechnology, at http://ific.orgtfood/biotechnology.vtml (last visited July 27. 2001).
Biotechnology offers more specificity in gene transfer by providing the technology to
move single genes, as opposed to thousands of genes using traditional cross-breeding
techniques, which will reduce the chance of transferring unwvanted genes. hl.; see also
Lara Beth Winn, Special Labeling Requirements for Genetically Engineered Food: How
Sound Are the Analytical Frameworks Used by FDA and Food Producers?. 54 FOOD &
DRUG L.J. 667, 668 (1999) (noting that "[glenetic engineering allows plant breeders to
get more precise results in a shorter amount of time").
31. "In fact we consume posting of DNA every time we eat anything, as it is
present in all plant and animal material." Posting of Dr. Richard H. Phipps. GM Crops:
An Alternative View to Greenpeace, FEED COMPOUNDER, June-July 2000, at 1, to
Agbioview@listbot.com (Aug. 31, 2000) (on file with author).
32. DNA, an abbreviation for deoxyribonucleic acid, is located in the nucleus of
all plant and animal cells. See generally LAURALEE SHERWOOD. FUNDA %E:-rtS Of;
PHYSIOLOGY: A HUMAN PERSPECrIVE B-1 to B-14 (2d ed. 1991). All plants and animals
are "composed of cells" and thus filled with genetic material. WILLIA K. PURVES ETr
AL., LIuE: THE SCIENCE OFBIOLOGY 60 (3d ed. 1992).
33. Human chromosomes which carry the traits for, among others, hair color, eye
color, and height, that are unique to every individual, are comprised of stretches of DNA
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the production of proteins 34 and thus plays an important role in
establishing the primary structure and function of the plant or animal as
a whole.35
A gene is a "stretch of DNA," which is responsible for encoding, or
directing the production of, a particular protein. Proteins are those
chemical substances that dictate the ultimate traits of a plant or animal,37
such as color, height, microbial resistance, and nutritional content. By a
process of natural selection,38 the plants and animals carrying the most
successful DNA code, and thus the most suitable traits, will survive over
those with less suitable traits for the environment in which the organism
lives. 39 Thus, by a process of natural selection, the world has inherent in
it an evolutionary method to weed out the less desirable traits of an
organism in favor of more desirable traits.40 Evolution, therefore, is a
consistent process of genetic modification 41 that enables change and
improvement within a species over time.
Like the process of natural selection, genetic technologies used in food
development are designed to foster the survival of the most desirable
material. A human child exhibits traits based on a combination of genetic material
received from his or her mother and father. For an overview of patterns of inheritance
and how traits are genetically determined, see PURVES Er AL., supra note 32, at 207-35.
See also DANIEL L. HARTL, GENETICS 40-45 (3d ed. 1994).




38. Charles Darwin is responsible for developing the evolutionary theory of
natural selection in 1858 as described in his famous book, The Origin of Species. See
PURVES ET AL., supra note 32, at 15-16. The theory is based on the fact that no two
individuals are exactly the same and that there is some genetic variation between two
individuals (i.e., no two individuals carry exactly identical genetic codes) with the
exception of identical twins. Darwin reasoned that the genetic variations affected the
probability of survival of that particular individual, and thus a survival of the trait which
enabled that individual to survive and not the other. Darwin "saw close parallels
between artificial selection by breeders and selection in nature." Id. at 15.
One example of the natural selection theory was demonstrated by a study on finches in
the Galapagos Islands. Due to an unusually long drought in 1977, it was determined that
finches with larger bill sizes were better adapted to the environment and thus survived
the drought whereas those with smaller bill sizes were unable to do so. Id. at 411. Due
to the deaths of several smaller billed birds, natural selection resulted in a larger group of
individuals carrying the trait for a larger bill and thus a higher probability that such a trait
would be passed along to future generations. Id. For an overview of the development of
the theory of evolution, which is based only in part on the theory of natural selection, see
id. at 400-19.
39. See id. at 15-16.
40. See id.
41. One of the basic forms of genetic variation comes from genetic mutation,
which is defined as any "heritable change in genetic material." HARTL, supra note 33, at
459. Mutation can occur spontaneously or due to exposure to a "mutation-causing
agent." Id. at 460. Although cells are equipped with the ability to repair mutations in
DNA, a mutation can occur in any cell and may be very difficult to detect. Id.
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plant or animal species.42  The use of genetic technology and cross-
breeding of plant material for desired characteristics is not a new
phenomenon43 as some opponents of GM foods today might think.
Traditional plant breeding techniques date at least as far back as the late
1800s, when Gregor Mendel applied a cross-breeding method using pea
plants to study character trait inheritance. 44 Traditional cross-breeding
techniques involve a selective mating between two like organisms (a fish
with a fish or a pea plant with a pea plant) resulting in a genetically
modified offspring that carries a combination of traits (encoded by the
genes) from the original parents. 45 Using this method, scientists were
eventually able to identify and select particular traits in order to generate
organisms with more desirable characteristics. Scientists no longer had
to wait for the long-term evolutionary genetic modification process to
take effect.
46
One of the main disadvantages of the traditional cross-breeding
technique, however, is the time it takes for the mating of the genes to
occur47 Because obtaining offspring with more desirable trait characteristics
can take multiple crosses, and therefore multiple generations of offspring,
the process can take many years.48 Another major problem that hinders
the use of the traditional method is that many genes are transferred when
two organisms are crossed thereby making it harder to obtain the desired
42. The process of artificial selection, or generating an organism with particular
desired characteristics, has been done through cross-breeding--the mating of two
different plant strains-for many years. PuRVEs E" AL. supra note 32. at 324. In fact.
cross-breeding was used in the 1930s to hybridize, (or generate) corn from two
genetically dissimilar plant strains, and in the 1950s to enhance wheat and rice
production. Id.
43. See Thompson, supra note 29, at http./vww.fda.gov/fdacifeatures0-000/100
_bio.htrl. For a general overview of traditional versus modem genetic enhancement
techniques and how they have been used in plant modification, see Statement of Policy:
Foods Derived from New Plant Varieties, 57 Fed. Reg. 22,984, 22,985-86 (May 29,
1992).
44. For a more detailed discussion of Mendel's famous experiments, see HARTL.
supra note 33, at 2.
45. For a general overview of the use of "plant breeding [as] a form of genetic
engineering," and its impact on the development of agriculture, see PURvES ET AL. supra
note 32, at 324.
46. Id.
47. See supra text accompanying note 30.
48. Depending on the length of time for the species to reproduce, creating a new
generation of organisms generally takes more than twelve years. See John Henkel.
Genetic Engineering Fast Fonvarding To Future Foods, at http.//wvww.fda.gov/bbs/
topics/CONSUMER/geneng.html (ast modified Feb. 1998).
trait without the possibility of combining undesirable traits as well.49
Using the more advanced recombinant DNA technology, 50 scientists
are able to select specific genes from one organism and insert them into
the genome of another without actually breeding or mating the two.
51
This method greatly decreases the time necessary to create a modified
organism and expands the possibilities of genetic engineering by
providing scientists access to a much wider variety of genes from which
to choose.5 2 The new technology, then, applies a standard technique in a
more efficient and specific manner. This added efficiency and
specificity should therefore serve to make genetically altered foods safer.
Regardless, it is the possibility of taking a gene from one organism and
inserting it into a different type of organism, one from a fish to a tomato
for example, which has created enhanced health concerns and public fear
that did not exist before.
54
Many products on consumer shelves today were developed, at least in
part, using genetic modification techniques.55 Using the more traditional
49. PURVES ET AL., supra note 32, at 324.
50. For a detailed discussion on the use of recombinant DNA technology, see
HARTL, supra note 33, at 351-83; PURVES ET AL., supra note 32, at 306-27; Methods for
Genetically Engineering a Plant, FDA CONSUMER (Jan.-Feb. 2000), at http://www.fda.
gov/fdac/features/2000/biochart.html; see also Statement of Policy: Foods Derived from
New Plant Varieties, 57 Fed. Reg. 22,984, 22,985-86 (May 29, 1992).
51. "Foreign DNA can be introduced into a cell" by using Recombinant DNA
technology, also referred to as "'genetic engineering' or "'cloning."' PURVES ET AL.,
supra note 32, at 306. Unlike traditional cross-breeding techniques that required a
mating between the foreign DNA donor and the recipient, recombinant DNA techniques
can be conducted in the laboratory. Id. For a general overview of the technique, see id.
at 306-27. The more traditional technique has been found significantly limited in
comparison to recombinant DNA technology because it can only be used between
organisms that can "interbreed with one another." Id. at 324. The cross-breeding
technique is also less efficient because it involves a mating of two entire genomes and
therefore can result in a combination of "unwanted genes" and desired genes. Id.
52. See id.; supra text accompanying note 30.
53. See supra text accompanying notes 30, 51.
54. See supra text accompanying notes 1-3. Opponents to GM foods are fearful,
for example, of modified products like potato chips with chicken genes, apple juice
containing silk moth genes, or corn tortilla chips with firefly genes. See Union of
Concerned Scientists, Transgenic Cafg, at http://www.ucsusa. org/food/tcmenu.html (last
visited July 15, 2001). In its recent proposal, the FDA agrees that this added efficiency
gives rise to the need for a more careful review of GM foods before marketing. See
Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4706, 4709 (proposed
Jan. 18, 2001) (to be codified at 21 C.F.R. pts. 192 & 592).
Given the efficiencies of rDNA techniques, the advances in these techniques,
and the rapidly expanding information related to genomes, FDA expects that
these techniques are likely to be utilized to an increasingly greater extent...
and that the products of this technology are likely in some cases to present
more complex safety and regulatory issues than seen to date.
Id. However, the FDA continues to find that GM foods in general are safe, therefore
requiring mandatory safety testing but not mandatory labeling. Id.
55. "More than fifty genetically engineered crops, including corn, squash, and
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selective breeding technologies, for instance, European scientists created
cabbage, brussels sprouts, broccoli and cauliflower by exploiting
specific traits of the wild mustard seed.56 In the year 2000, GM seeds
were expected to supply 38% of the United States' corn crop, 57% of the
soybean crop, and 70% of the canola crop.5 It is estimated that more
than fifty genetically engineered crops are currently on the market,
including squash and the infamous "Flavr Sav" tomato.5 8 Genetic
technologies have likewise been employed in animals. Take the famous
rbST cow,59 for example, that through modem GM techniques was given
the capability to produce more milk than other cows.6
tomatoes, already have entered commercial production." Deborah Silver, Gene Labeling
Not a Must, RESTAuRANTS & INSTITUmONS, June 15, 2000, at 86: see also International
Food Information Council Foundation, Background on Food Biotechnology. at
http://ific.org/food/biotechnology.vtml (last visited July 27, 2001). Approximately 70%
of grocery store food may include genetically altered material. See Barboza. supra note
17, at Al. For a listing of approved GM food products see Union of Concerned
Scientists, Foods on the Market, at http://www.ucsusa.org/agriculture/gen.market.html
(ast visited July 23, 2001); Genetically Modified Crops Approved by tie FDA. at
http:llwww.nutrinews.comlpubliclshowArticle.cfm?objectlD=63793F9C-86E2-4B 15-B6
6A78C91EF9F943 (last visited Jan. 11, 2001).
56. PuRvEs Er AL, supra note 32, at 402; see also J. Howard Beales 111.
Modification mid Consumer Ifonnation: Modern Biotechnology and tie Reguation of
Infonnation, 55 FOOD & DRUG L.J. 105, 105 (2000).
57. Mark Albright, Biotech Battle Becomes a Campaign of Words, S.A-% DtEGo
UNION-TRm., May 11, 2000, at C2.
58. See Silver, supra note 55. The Flaw Savr tomato, genetically enhanced to stay
firm for a longer period of time and therefore to taste better, was the first GM food to be
approved for sale by the FDA and complete the FDA's voluntary consultation process.
See Karen A. Goldman, Labeling of Genetically Modified Foods: Legal and Scientific
Issues, 12 GEo INT'L ENvTiL L. REv. 717, 735-36 (2000). Like GM foods in general.
the FDA found the Flaw Savr to be "as safe as tomatoes bred by conventional means."
Id. at 736. After a review of the new product and a comparison to traditional varieties.
the FDA determined that the Flavr Saw did not require "special labeling ... based on its
assessment that the Flaw Savr 'maintains the essential characteristics of traditionally
developed tomatoes."' Id.
59. See discussion infra Part V.A.I. In 1993, the FDA approved the use of rbST
(recombinant bovine growth hormone) for injection into dairy cows to generate an
increase in milk production. See Interim Guidance on the Voluntary Labeling of Milk
and Milk Products from Cows that Have Not Been Treated with Recombinant Bovine
Somatotropin, 59 Fed. Reg. 6279 (Feb. 10, 1994). Vermont attempted to require that
such milk be labeled, but the law mandating labeling w%-as challenged by dairy
manufacturers in the Second Circuit and overturned. Int'l Dairy Foods Ass'n v.
Amestoy, 92 F.3d 67, 73 (2d Cir. 1996). For additional background and discussion
about rbST milk and the labeling debate, see Kathleen Lennon, Government's Udder
Disregard for a Consuner's Right to Infonnation on RBST: Mandatory Labeling of Milk
Products Should Be Allowed, 22 VT. L. REV. 433 (1997).
60. See supra text accompanying note 59.
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The food industry has applied modem GM techniques since the 1970s
and not one report of harm due to the new modification process has yet
been documented.6' Additionally, the same genetic techniques have
been used to generate GM drugs for at least twenty-five years with no
evidence that the process itself is harmful. 62 The scientific community
continues to advocate, based on the lack of demonstrated harm and the
fact that foods have been genetically modified for hundreds of years, that
modem GM technologies do not pose any additional risk of harm when
compared to crops generated using traditional forms of genetic
enhancement. GM opponents, on the other hand, argue that modem GM
technologies are simply different and that a lack of evidence of harm
should not amount to a presumption of safety.63
B. Opposition to GM Foods and the Precautionary Principle
What are the specific concerns that GM opponents raise? Although
they identify a long list of potential risks that GM foods may pose, the
answer is none that have shown any scientific validity.' 4 In fact, after
61. Elizabeth Whelan, The Case for Genetically Modified Food, at
http://www.nutrinews.com/public/showArticle.cfm?objectlD=7C4DBF9A-95FD-4939-B
E591EBDD62B1 157 (last visited July 23, 2001). Potential hazards have been identified,
such as the potential introduction of new allergens to a food product; however, the
hazards that arise are not unique to modem GM technologies. Such hazards arise due to
the nature of the trait introduced, not the process of genetic modification. Id.
62. See id. It is interesting that GM drugs have not met the same resistance as GM
foods since both are created using the same modem genetic technologies. It has been
suggested that the clear benefits of pharmaceuticals leave consumers less concerned. See
infra text accompanying note 310.
63. See Claire Robinson, The Case Against Genetically Engineered Food, at
http://www.nutrinews.com/public/showArticle.cfm?objectlD=1555769 I-BE38-4F4B-A2
9EE688ED9EB07D (last visited Feb. 26, 2001).
64. According to Dr. C. S. Prakash, Professor of Biotechnology and advocate for
the scientific community, "[tihere is no scientific reason to believe that genetically-
engineered foods are any less safe than the foods we've been eating for centuries." What
the Experts Say About Food Biotechnology, at http://ificinfo.health.org/foodbiotech/
whatexpertssay.htm (Feb. 2000). Although there have been no examples in commercial
food products where the risk has proven to be real, opponents of GM foods claim that
such foods may set off allergies, create new toxic compounds, or cause antibiotic
resistance. See What Are They Hiding, at http://www.gefoodalert.org/html/hiding.htm
(last visited Sept. 25, 2000). Opponents base the need for labeling on these concerns.
Id.
However, under the mandatory consultation process conducted by the FDA (which
requires that each of these concerns is evaluated to establish food safety before
commercial release of the food), any identifiable changes in food content like added
toxic compounds, allergens, or safety hazards would subject (and always have subjected)
the product to rejection by the FDA (or mandatory labeling requirements as an
alternative) where safety is at risk. See generally Statement of Policy: Foods Derived
from New Plant Varieties, 57 Fed. Reg. 22,984 (May 29, 1992).
Opponents have also identified environmental risks such as increased weediness, gene
transfer (by pollination for example) to wild relatives of the GM food, and the creation of
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considering more than 50,000 written comments regarding the FDA's
proposed 2000 labeling policy, the FDA determined that those "comments
[from individuals requesting mandatory labeling] were mainly
expressions of concern about the unknown." 6 GM opponents claim that
GM foods may contain new allere~ns or toxins thereby creating enhanced
safety risks, or that GM crops might cause environmental problems by
contaminating non-GM crops.66 Because it is possible that such hazards
could result, just as it is also possible that these very same hazards may
result with any new food product introduced to consumer shelves,67 the
FDA has, for many years, evaluated new food products for exactly the
speculative risks that GM opponents identify68 as sufficient to demand
new plant viruses to be associated with GM technologies. See Union of Concerned
Scientists, Fact Sheet: Risks of Genetic Engineering, at http://www.ucsusa.org/
agriculture/gen.risks.html (last visited Sept. 25, 2000). The FDA is also required to take
into consideration environmental impacts when making decisions to approve products
for sale in the United States. See Statement of Policy: Foods Derived from New Plant
Varieties, 57 Fed. Reg. at 23,004. Thus, the concerns raised by opponents to GM have
been, and continue to be, addressed by the FDA through a consultation process with food
manufacturers. Generally, if any of these risks proved true, the product would not likely
make it to consumer shelves; if it did, it would be required to contain an appropriate
label under the Federal Food, Drug and Cosmetic Act (FFDCA). See id. at 22,99 1.
65. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg.
4839,4840 (Jan. 18, 2001).
66. See supra text accompanying note 64; see also L.L. Wolfenbarger & P.R.
Phifer, The Ecological Risks and Benefits of Genetically Engineered Plants, 290 ScleCE
2088 (Dec. 15, 2000); GM Plants: Panacea or Plague: Fears & Facts About GM Plants,
at http:lwvw.botany.about.comsciencelbotanylibrary/weekly/aaOlO3Olb.htm (last
visited Feb. 26,2001); Claire Robinson, The Case Against Genetically Engineered Food,
at http://www.nutrinews.com/public/showarticle.cfm?ObjectlD- 15557691 -BE38-4F4B-
A29EE688ED9EB07D (last visited Feb. 26, 2001); Safer Food, Safer Farms Campaign
-The Need for Labeling Genetically Engineered Foods, at http'/%vww.foe.org/safefood/
factsheetge.html (last visited Feb. 26, 2001).
67. There are 10,000-20,000 new food products introduced to consumer product
shelves every year. See John Henkel, Genetic Engineering Fast Fonarding to Future
Foods, FDA CONSUMER, available at http://www.fda.gov (last modified Feb. 1998).
Only a small handful of this batch of new food products, those with additives like
artificial sweetener, require premarket approval by the FDA so long as the ingredients
used are generally recognized to be safe. Id.
68. See supra text accompanying note 64 for a discussion of the factors that the
FDA considers when consulting with food suppliers prior to allowing the product to be
sold. See also infra text accompanying note 105. In fact, the FDA's new policy
mandates that new GM products are tested for exactly the specified risks that GM
opponents raise. See Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg.
4706, 4709-15, 4717 (proposed Jan. 18, 2001) (to be codified at 21 C.F.R. pts. 192 &
592) (requiring GM food suppliers to test and report to the FDA particular data and
information on any new GM food, including the information needed to determine if the
mandatory labeling.
Those that oppose GM foods essentially argue that there are too many
uncertainties with GM foods. Opponents to GM claim that not enough
testing has been done to ensure that such products are one hundred
percent safe for human consumption or that they do not pose a risk of
harm to the environment. 69 As with any new technology, it is true that
unforeseen risks may exist, and it is this fear of the unknown that truly
drives the opposition to GM foods. Opponents worry that the
introduction of GM foods could, like the introduction of certain other
products in the past, result in some unforeseen disaster.7 4
Anti-GM advocates urge regulators to apply the "precautionary principle'
when demanding mandatory labeling or a halt to GM food production to
avoid any possibility of future harm. The precautionary principle calls
for "precautionary measures" to be taken whenever a threat to public
safety or the environment arises from a particular activity regardless of
whether it can be shown that the activity actually causes the identified
risk.72 It has been called the "better... safe than sorry" principle.73
If applied to GM foods, the precautionary principle would require the
impossible: that scientists prove to a certainty that GM foods are
absolutely safe. Like any new food product (or any new consumer
product for that matter) it cannot be shown to a certainty that no risk
exists. Applying the precautionary principle to GM technologies could,
in fact, be more hazardous than any risk that may later surface because
the principle does not take into account the potential risks that arise from
banning, restricting, or overregulating the use of such a promising new
technology.74 In other words, applying the precautionary principle, as
new food contains allergens, food additives, compositional differences, or is otherwise
adulterated).
69. Julie Teel, Regulating Genetically Modified Products and Processes: An
Overview of Approaches, 8 N.Y.U. ENvTL. L.J. 649, 650, 655-61 (2000).
70. See Claire Robinson, The Case Against Genetically Engineered Food, at
http://www.nutrinews.com/public/showArticle.cfm?objectlD= 1555769 l-BE38-4F4B-A2
9EE688ED9EB07D (last visited Feb. 26, 2001). Opponents cite nuclear power, DDT
and "mad cow" disease as examples where technology that was originally believed safe
was later found to generate unforeseen risks. Id.
71. The precautionary principle is "the idea that new technologies and substances
should be regulated before they can cause harm rather than after their harmful potential
has been demonstrated." Jonathan H. Adler, More Sorry than Safe: Assessing the
Precautionary Principle and the Proposed International Biosafety Protocol, 35 TEX.
INT'L L.J. 173, 194 (2000).
72. INDuR M. GOKLANY, APPLYING THE PRECAUTIONARY PRINcIPLE TO GENETICALLY
MODIFIED CROPS 2 (Aug. 2000), available at http://www.agbioworld.org/pdf/PP-
andGMCrops--_GOK/anyl.pdf.
73. Adler, supra note 71, at 194.
74. A ban on GM foods, contrary to the claims of its proponents, would be
imprudent rather than precautionary. The precautionary principle-properly
applied, using a broader consideration of the public health and environmental
[VOL- 38: 893,2001] Labeling Of Genetically Modified Foods
SAN DIEGO LAW REVIEW
opponents suggest, ignores the potential hazards of NOT using GM
techniques, i.e., the benefits of GM foods.75 "The unfortunate reality is
that efforts to regulate one risk can create other, often more dangerous
risks."
76
Pro-GM and anti-GM groups alike agree that additional testing is
needed.77 However, halting the use of GM technologies-directly in the
form of a ban or indirectly by requiring labeling of GM products-due
to a fear of the unknown is not a rational science-based solution to
managing potential risks. In order to enjoy the benefits of a new
technology, while at the same time protecting against real future risks, a
cost-benefit analysis78 must be employed on a case-by-case basis instead
consequences of a ban-argues instead for a sustained effort to research,
develop, and commercialize GM crops, provided reasonable caution is
exercised during testing and commercialization of these crops.
GOKLANY, supra note 72, at 25; see also Adler, supra note 71, at 195 (explaining that the
real question that should be asked is whether the costs of the precautionary regulation
exceed the benefit of the regulation); ExxonMobil Corp.. Unbalanced Caution, N.Y.
Ti MEs, Nov. 2, 2000, at A31 (expressing concern over abuse of the precautionary
principle by ignoring scientific findings of safety in the pursuit of a nonexistent risk-free
activity).
75. GOKLANY, supra note 72, at 25.
76. Adler, supra note 71, at 195. A good example of the potential pitfalls of
resistance to biotechnology enhanced foods centers on the growing human population
and the corresponding need to produce more food and other materials on a planet that is
not increasing in size. Although it is true that feeding and clothing the gro%% ing world
population can be done without GM, the choice to avoid GM results in the need for more
land devoted to farming. Opponents claim that the use of GM could lead to insect
resistance or create superweeds, thus changing environments in a negative way;
however, not using GM and instead choosing to use more land to satisfy the demands of
a growing world would obviously lead to great environmental damage as habitats are
destroyed to be used for these purposes. See id. at 201. Loss of habitat has been
attributed as the cause, for instance, of more than "one third of documented animal
extinctions." Id. Thus, habitat destruction may be the greatest source of risk to
biological diversity at this time. Id. There is a choice between sacrificing more land to
meet growing demands or relying on GM or other technologies to increase yields
without the need to destroy more land. The costs and benefits of each should be
compared before determining which is really more environmentally healthy.
77. After a review of scientific literature available dealing with environmental
risks and GM, it has been concluded that "[nleither the risks nor the benefits of
[genetically engineered organisms] are certain or universal." Volfenbarger & Phifer,
supra note 66, at 2092. Further research and comparisons are called for with the
recognition that it is not possible to accurately predict with certainty what the ecological
consequences of introducing any new species would be. See id.
78. See Adler, supra note 71, at 205. "If the goal is to minimize risk. the focus
should be on which risk is greater-the risk of a new technology, or the risk of doing
without it." Id. "The presence of uncertainty about a technology, without more, cannot
establish a presumption that more regulation is required." Id.
of the precautionary-only policy suggested by anti-GM advocates.
The bottom line in the debate today is that no valid scientifically based
objection to modem genetic technologies currently exists. Rather, anti-
GM groups have launched a successful lobbying campaign based only
on speculation.80 There is no reason to assume that new GM foods are
any more of a hazard to human health than any other foods, or that the
FDA's regulations are not adequate for addressing any safety risk that
may arise. For precisely these reasons, the FDA has rightfully found
that mandatory labeling is not the answer for dealing with unrealistic
consumer fears. Further research and testing of GM products, not the
consumer oriented food product label, will be the forum to address the
concerns raised by opponents to GM.
C. GM Food-Labeling Regulation
Three main regulative bodies are responsible for monitoring food
labeling in the United States: (1) the FDA, (2) the U.S. Department of
Agriculture (USDA), and (3) the Environmental Protection Agency
(EPA).8 While the USDA and the EPA play important roles in the
regulation of GM products, the majority of GM foods fall within the
realm of the FDA's regulatory authority.82  The FDA is primarily
responsible for ensuring the safety of the public from harmful food
products under the Federal Food, Drug and Cosmetic Act (FFDCA) of
1938.83
Pursuant to its duty to protect the public safety under the FFDCA, the
FDA has spent several years reviewing scientific reports and public
79. In fact the FDA's new policy is designed to "foster[] a case-by-case approach
to address[] relevant scientific and regulatory issues rather than a single set of tests that
likely would not be applicable in all circumstances." Premarket Notice Concerning
Bioengineered Foods, 66 Fed. Reg. 4706, 4717 (proposed Jan. 18, 2001) (to be codified
at 21 C.F.R. pts. 192 & 592).
80. See supra text accompanying note 64. Because none of the food products
currently on consumer shelves exhibit safety risks, the risks identified are no more than
mere speculation at this time. See supra text accompanying note 1; infra text
accompanying note 105.
81. The FDA is primarily responsible for monitoring food safety and labeling
involving foods derived from crops or biotech plants as well as the safety of animal feed
products. The USDA is responsible for reviewing field-testing of GM plants and other
environmental safety issues, while the EPA focuses its efforts on regulating pesticide use.
See Thompson, supra note 29, at httpY/www.fda.gov/fdaclfeattmst2000/I0_ bio.html; see
also Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg. 22,984,
22,985 (May 29, 1992); Premarket Notice Concerning Bioengineered Foods, 66 Fed.
Reg. at 4708. Food advertising issues are regulated by the U.S. Federal Trade
Commission. See Backgrounder-Food Labeling, at http://ificinfo.health.org/ backgrnd/
bkgr5.htm (last visited July 14, 2000).
82. See supra text accompanying note 81.
83. 21 U.S.C. §§ 301-95 (1994).
910
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comments concerning the use of GM technologies.8 The FDA
announced its first policy relating to GM food products in 1992. The
1992 policy, as it is now called, declared that GM plant products were
no different from other traditional plant products and granted them
"GRAS" (Generally Recognized As Safe) status.85 In May 2000, after
eight additional years of scientific review, the FDA announced similar
findings as to the safety of GM foods. 6 However, unlike the 1992
policy, the FDA decided to adopt a mandatory consultation process,
requiring a more strict review of GM products before they enter the
market.' In both policies, the FDA determined that mandatory labeling
of GM foods is not proper due to the lack of scientific evidence pointing
to a risk of harm to the public.8 8 The FDA's decision to focus on
voluntary labeling guidelines and a mandatory consultation process is
consistent with its obligations under the FFDCA and its prior treatment
of similar food products.
89
Im. FDA'S VOLUNTARY LABELING PROGRAM AND MANDATORY
CONSULTATION PROCESS IS CONSISTENT WITH FFDCA
REQUIREMENTS AND LEGAL PRECEDENT
Although the debate continues in the public arena and in legislative
forums,9" the FDA decision not to mandate labeling for GM foods9'
where no general safety risk can be scientifically validated is an
84. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed.
Reg. 22,984, 22,984 (May 29, 1992).
85. Id. at 22,990. Because DNA exists in every food product and the use of GM
techniques involves only a change in the method of production, the FDA found that
transferred genetic material "do[es] not raise a safety concern as a component of food.
In regulatory terms, such material is presumed to be GRAS." Id.
86. Press Release, Food and Drug Administration. FDA to Strengthen Pre-Market
Review of Bioengineered Foods, at http:/www.fda.gov/bbs/topics/NEWS/NEWO
0726.html (May 3, 2000).
87. Id.; see infra text accompanying note 105.
88. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed.
Reg. at 22,991; Press Release, Food and Drug Administration, FDA to Strengthen Pre-
Market Review of Bioengineered Foods, at http:llv.fda.govbbshtopislNEWS/
NEW00726.html (May 3, 2000); Draft Guidance for Industry: Voluntary Labeling
Indicating Whether Foods Have or Have Not Been Developed Using Bioengincering;
Availability, 66 Fed. Reg. 4839, 4840 (Jan. 18, 2001).
89. See discussion of the rbST labeling debate izfra Parts IV.B. 1. V.A. L. see ,also
Degnan, supra note 25, at 301.
90. See supra text accompanying notes 13-14.
91. See supra text accompanying note 6.
important final decision in many respects. Because the FDA's decision
may undergo further scrutiny from opponents of GM technologies,
however, it is worthy to review the justification for this recent decision.
In so doing, the FDA resolution can be found consistent with its
statutory duties under the FFDCA and legal precedent.
A. FDA Decision Is Consistent with Its Statutory Duties
Under the FFDCA
Under the FFDCA, the FDA is charged with "protect[ing] the public
health by ensuring that... foods are safe, wholesome, sanitary, and
properly labeled."92  If a food product poses a significant hazard to
public safety, the FDA may ban the product entirely from consumer
shelves.93 If the product creates only a minor risk to public safety,
however, the FDA may choose to balance that risk with the benefits of
the product, 94 focusing first on whether the product should be sold at all.
If the benefits outweigh the risks, the FDA will then properly consider
the consumer's right to be made aware of the risks and enforce
appropriate warning regulations. 95 Labeling guidelines have generally
been established under the FFDCA to alert the consumer to reasonable
safety risks9 6 with the assurance that only accurate and truthful information
92. 21 U.S.C. § 393 (1994).
93. As part of the FDA's mission to protect the public health, such activity has
been found warranted under the FFDCA. See 21 U.S.C. §§ 301-95 (1994); Statement of
Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg. 22,984, 22,988-89 (May
29, 1992).
94. See discussion infra Part IV.A.I. The FDA employed a balancing test, for
example, when determining that mandating nutrition content labeling was warranted to
assist consumers in lowering weight, reducing coronary heart disease, decreasing cancer
rates, managing diabetes, and adhering to religious and other dietary preferences. This
mandate was initiated in the face of a cost far exceeding 100 million dollars. See Food
Labeling; Declaration of Ingredients, 56 Fed. Reg. 28,592, 28,616-17 (June 21, 1991).
95. Whenever a safety risk exists, the FDA requires a warning label identifying the
hazard for those products that are approved for sale. See Food Labeling; Declaration of
Ingredients, 56 Fed. Reg. at 28,615.
However, FDA is unwilling to require a warning statement in the
absence of clear evidence of a hazard. If the agency were to require
warnings for ingredients that only cause mild idiosyncratic
responses, it is concerned that it would overexpose consumers to
warnings. As a result, consumers may ignore, and become
inattentive to, all such statements.
Id.
96. The FDA has developed specific guidelines to deal with known risks and the
labeling of products that are sufficiently safe to be sold to consumers yet demonstrate a
small degree of safety risk. See generally 21 U.S.C. §§ 301-95. In particular, the FDA
has established particular guidelines to deal with "adulterated" foods, "misbranded"
foods, the use of Saccharin in foods, tolerances for "poisonous substances" or "pesticide
residues" in food products, food additives, new dietary ingredients, and infant formulas,
all of which are designed to offer protection to consumers from harm and to enable
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is provided on the label.97
Unless a significant safety risk exists or there is a sincere need for
consumers to distinguish between food products before purchase, the
FDA hesitates to mandate labeling of food products.9 The FDA generally
reserves mandatory labeling for cases where a warning is required to
protect the consumer from harm.99 Labeling has also been required to
provide nutritional content information l°o in cases where the consumer
has sufficient capacity and knowledge to compare labeling content and
therefore choose between different food products. Where no recognized
safety risk has been identified or it is determined that label information
would not assist a consumer in distinguishing between products, the
FDA has focused on establishing voluntary labeling guidelines instead.,,,
In accordance with its duty to protect the public safety and monitor
food labeling guidelines, the FDA has decided to treat GM foods just as
it treats any other type of food product.0 2 In finding no recognizable
difference between GM products and their corresponding non-GM
products, and no valid safety risk from GM products in general, the FDA
has determined that mandatory labeling is not within its power.0 -
The FDA has already approved several GM foods for sale"° based on
a careful review of each individual product's safety. Only after many
years of testing and experience with GM foods has the FDA been able to
reach its conclusion that GM products are just as safe as comparable
unmodified food products. 05 Thus, because the FDA did not find a
consumers to make healthy food choices. Id.
97. See 21 U.S.C. § 343 (1994).
98. See supra text accompanying notes 93-95; see also discussion infra Part
IV.A.1 (concerning the rbST labeling debate).
99. See supra text accompanying notes 95-96.
100. Mandatory nutritional labeling of food products was added to the FFDCA in
1990 under the Nutrition Labeling and Education Act of 1990. H.R. 3562. 101' a Cong.
(1990) (enacted); see 21 U.S.C. §§ 343 (q)-(r), 343-1 (1994).
101. See discussion inifra Part IV.A.1.
102. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed.
Reg. 22,984, 22,989 (May 29, 1992); Press Release, Food and Drug Administration.
FDA to Strengthen Pre-Market Review of Bioengineered Foods, at http/Iwv..fda.gov/
bbs/topicsINEWS/NEWO0726.html (May 3, 2000).
103. See Press Release, Food and Drug Administration, FDA to Strengthen Pre-
Market Review of Bioengineered Foods, at http:llwww.fda.govlbbsltopicslNEWSI
NEW00726.htnl (May 3,2000).
104. See supra text accompanying note 55. See the FDA Web site for a full list of
approved products and a general overview of the FDA's treatment of bioengineered
foods at http://vm.cfsan.fda.gov.
105. See supra text accompanying note 1. The FDA has been reviewing scientific
safety risk or any sort of difference between the final GM food products
and their non-GM counterparts, the FDA did not have the power to
mandate labeling when properly taking into account the goals of the
FFDCA 10 6 and legal precedent. 0 7
B. Legal Precedent Prior to and Following the
Decision are Consistent
While the GM food labeling debate is not generally fought in the
courtroom, two recent cases are important to settling the labeling debate
in the United States. The first, International Dairy Foods Association v.
Amestoy,10 8 decided prior to the FDA's May 2000 decision, involved the
rejection of a mandatory labeling law in Vermont that sought to identify
biotechnology-enhanced milk products. The second, Alliance for Bio-
Integrity v. Shalala,'O° decided four months after the FDA's May 2000
decision, rejected outright a challenge to the FDA's policy concerning
data and voluntary consultation information with GM food producers for close to a
decade. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg.
at 22,984. While the consultation process has been only voluntary up to this point, the
FDA claims that "[iut has been the general practice of the food industry to seek informal
consultation" with the FDA before offering a new food product to market. Id. at 22,991.
In its first policy announcement concerning bioengineered plant products in 1992, the
FDA found that "experience over many years (or even centuries)" demonstrated that
foods derived from new plant varieties did not require routine safety checks and could be
treated like any other food product. Id. at 22,988-89. With the May 2000
announcement, however, the FDA has mandated that all food producers consult with the
FDA prior to introduction of a new GM food product. See Press Release, Food and Drug
Administration, FDA to Strengthen Pre-Market Review of Bioengineered Foods, at
http:/www.fda.gov/bbs/topics/NEWS/NEW00726.html (May 3, 2000). The consultation
process typically consists of a review of the crop from which the product is derived, the
applications or uses of the food, the sources and function of GM material introduced, the
intended technological effect of the modification, information concerning known
allergenicity and toxicities, and "the basis for concluding that [such] foods ... can be
safely consumed." See Guidance on Consultation Procedures; Foods Derived from New
Plant Varieties, at http://vm.cfsan.fda.gov/~Ird/consulpr.html (Oct. 1997).
106. The main goal of the FDA with regard to GM foods is to ensure food safety
under the FFDCA and to work closely with the EPA and USDA in regulating a safe food
supply in the United States. See Statement of Policy: Foods Derived from New Plant
Varieties, 57 Fed. Reg. at 22,985. Under the guidance of the FDA, the United States has
developed one of the safest food supplies in the world. See id. at 22,988.
107. See discussion infra Part III.B. For a more detailed scientific analysis of GM
foods under the FFDCA, finding that "[c]urrent U.S. policy does not require mandatory
labeling of genetically modified (GM) foods as a class," see Goldman, supra note 58, at
718. Because GM techniques have been found not to alter the final food product and
only to involve a small change in the method of production, and because the FDA can
only require mandatory labeling when the final product is different in some identifiable
way, the FDA is not required to mandate labeling for GM food products in general. See
id. at 725.
108. 92 F.3d 67 (2d Cir. 1996); see also discussion infra Part V.A.l.
109. 116 F. Supp. 2d 166 (D.D.C. 2000).
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GM foods in general. " °
International Dairy Foods evaluated the FDA's findings that rbST-
enhanced milk products were as safe and not nutritionally different than
other milk products on consumer shelves.' The second circuit court
used the FDA's position to determine that the state's mandatory labeling
law violated the food supplier's First Amendment rights. 2 Like rbST
milk, the FDA has determined that GM foods are as safe and not
nutritionally different from other similar products on consumer shelves.
Therefore, the rejection of mandatory labeling for GM foods is
consistent with the FDA's decision not to mandate labeling for rbST
milk. It is also consistent with the analysis provided in International
Dairy Foods that focused on limiting compelled speech to cases where
more than a consumer desire to have information exists." 3
Alliance for Bio-Integrity was filed prior to the May 2000 decision to
challenge the FDA's 1992 stance on the issue of GM foods, a stance that
is similar to the FDA's current position." 4 The plaintiffs in that case
were the first to oppose the FDA's policy on GM food labeling in
general, raising issues surrounding the consumers right to know,
religious freedom, environmental safety, and FFDCA statutory
construction." 5 The district court gave deference to the findings of the
FDA and rejected all claims."
16
Judge Kollar-Kotelly's opinion in Alliance for Bio-Integrit sets an
important precedent in the labeling debate. The district court reviewed
the limits of the FDA's power under the FFDCA and concluded that the
FDA has "limited authority to require labelin ," when the only 'justification
110. See id. at 181.
111. Int'l Dairy Foods Ass'n, 92 F.3d at 69.
112. 1& at73.
113. See discussion infra Parts IV.B. 1, V.A. 1.
114. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed.
Reg. 22,984 (May 29, 1992). The main difference between the 1992 position and the
2000 position is the decision to mandate a consultation process for GM foods to further
ensure safety of GM products on consumer shelves. See supra text accompanying note
105.
115. AllianceforBio-Iztegriiy, 116 F. Supp. 2d at 170.
116. Id. at 181.
117. Id. at 178. Under 21 U.S.C. § 321(n), the FDA can only mandate labeling if
the product is misbranded because it "fails to reveal facts... material with respect to
consequences which may result from the use of the article to which the labeling...
relates." 21 U.S.C. § 321(n) (1994). Under the FDA's declaration that GM foods are
not "materially" different from non-GM foods, then, a failure to identify the product as
GM is not misbranding. See Alliancefor Bio-ntegrity, 116 F. Supp. 2d at 179.
for such a requirement is consumer demand.""18 Judge Kollar-Kotelly
discusses when labeling is appropriate, indicating that where "'the
product does not differ in any significant way from what it purports to
be, then it would be misbranding to label the product as different, even if
consumers misperceived the product as different.""' 9 In upholding the
FDA's findings that GM foods in general are not materially different
than other foods, the court held that the FDA "lacks a basis upon which
it can legally mandate labeling, regardless of the level of consumer
demand."'2 0
Alliance for Bio-Integrity demonstrates the deference that courts will
likely give to FDA findings as well as the limitations that those scientific
findings place on the FDA when considering labeling initiatives. The
FDA has not interpreted the FFDCA to require a review of mere
consumer concern when evaluating "misbranded" products. Rather, the
FDA finds that its duty lies first in evaluating the scientific risks and
nutritional distinctions between products.' 2' Only where a material
difference can be found will the FDA rightly be able to consider the
consumer's interest and institute labeling regulations.'
22
Both International Dairy Foods and Alliance for Bio-Integrity define
the extent of the FDA's power concerning food product labeling where
the FDA's scientific findings show no risk of harm to consumers. In
these cases, a consumer's desire to know is not enough under the power
granted to the FDA by the FFDCA to warrant broad mandatory labeling
regulations. These decisions confirm that the FDA acted with the
support of legal precedent when determining that mandatory labeling is
inappropriate for GM foods in general.
C. FDA Decision Will Set Future Precedent and Regulations
As the courts in International Dairy Foods and Alliance for Bio-
118. Alliance for Bio-Integrity, 116 F. Supp. 2d at 179.
119. Id. (quoting Stauber v. Shalala, 895 F. Supp. 1178, 1193 (W.D. Wis. 1995)).
120. Id.
121. This is made clear in its proposed mandatory safety consultation program
announced in January 2001. See generally Premarket Notice Concerning Bioenginecercd
Foods, 66 Fed. Reg. 4706 (proposed Jan. 18, 2001) (to be codified at 21 C.F.R. pts. 192
& 592).
122. See Alliance for Bio-Integrity, 116 F. Supp. 2d at 179.
Plaintiffs fail to understand the limitation on the FDA's power to
consider consumer demand when making labeling decisions because
they fail to recognize that the determination that a product differs
materially from the type of product it purports to be is a factual
predicate to the requirement of labeling. Only once materiality has
been established may the FDA consider consumer opinion to
determine whether a label is required to disclose a material fact.
Id.
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Integrity ruled, courts and states currently reviewing mandatory labeling
initiatives must give deference to the findings of the FDA. States may
be subject to preemptory challenges, for example, if they adopt legislation
contrary to the FDA's GM policies. The focus of future federal
legislation, taking into account the FDA's conclusions, will be designed
to calm consumer fears and assure consumers that their safety is being
considered without mandatory labeling,2' Several bills have already
been proposed that would modify the FFDCA in light of the FDA's
recent findings. t24 For example, one U.S. Senate Bill proposes to amend
the FFDCA to require premarket consultation and approval of GM foods
in accord with the FDA's May 2000 decision to do the same.1' -
The FDA's stance has also prompted a review of European anti-GM
regulations1 26 and is likely to be important to other countries as they
consider whether to develop anti-GM legislation. The decision not to
mandate labeling for GM foods, then, is an important precedent in
settling the GM food labeling debate for good.
IV. THE CONSUMER'S RIGHT TO KNow Is NOT ABSOLUTE
The GM food labeling debate, unlike any other in history,12 7 brings the
consumer's right to know to the forefront. It helps define the limits on
the right to know especially as it relates to food products. The
consumer's right to know is not absolute and can be evaluated using a
balancing approach like that described below.' Striking the
123. S. 3184, 106th Cong. (2000) (modifying the FFDCA to require premarket
consultation and approval of GM foods); see also S. 2315, 106th Cong. (2000); H.R.
3883, 106th Cong. (2000) (called the "Genetically Engineered Food Safety Act.-
proposing several changes to the FFDCA); H.R. 5095, 106th Cong. (2000) (requiring
that the Secretary of Agriculture prepare a report concerning the risks and methods of
monitoring GM foods).
124. See supra text accompanying note 123.
125. S. 3184, 106th Cong. (2000). The bill was introduced in October 2000 and is
called the "Genetically Engineered Foods Act." Id.
126. The European Commission indicated that it is time "to accept that GM foods
do not pose a serious threat to public health," and thus decided to end its "unofficial 18-
month moratorium" on GM foods. Karen Birchard, European Commission to End De
Facto Moratoriwn on GM Products, LANCEr, July 22, 2000, at 320.
127. The rbST debate considered infra Part V.A. I is the closest relative to the GM
food labeling debate.
128. The balance may include the review of several factors not listed and
considered here, as the particular case may demand. Nonetheless, a balancing of
interests appears to be warranted whenever reviewing the extent of the consumer's right
to know.
appropriate balance of rights between consumers and food-product
suppliers requires the review of several factors including the consumer's
right to a safe food supply,' 2 9 the consumer's right to make knowledgeable
food choices,' 30 and the consumer's right to freedom of religion,' 3' as
well as the food supplier's right to freedom of commercial speech and
free trade.132  When applying this delicate balance to the GM food
labeling debate, the FDA was justified in finding mandatory labeling
inappropriate to protect the consumer's limited right to know.
A. Rights of the Consumer
The consumer has the right to consume safe food products. 33 The
consumer has the right to make knowledgeable food choices. 34 The
consumer also has the right to freedom of religion.135 Each of these
rights becomes important when evaluating the extent of the consumer's
right to know about the GM food products he consumes.
1. Consumer Safety
Although the FDA and the scientific community identify GM food
products as safe, 136 opponents argue that not enough research into GM
129. Federal regulatory agencies are charged with ensuring the safety of products
that reach consumer shelves under the Federal Food, Drug and Cosmetic act (FFDCA).
21 U.S.C. §§ 301-95 (1994). See supra text accompanying note 81. See generally
International Food Information Council Foundation, Background on Food Biotechnology,
at http://ific.org/food/biotechnology.vtml (last visited July 27, 2001). "Under the
[FFDCA], companies have a legal obligation to ensure that any food they sell meets the
safety standards of the law.... If a food does not meet the safety standard, the FDA has
the authority to take it off the market." Thompson, supra note 29, at
http.//www.fda.gov/fdacfeatures/ 2000/100_bio.html. The Clinton Administration announced a
new Food Safety Initiative in May 2000 designed to expand food safety research efforts.
See Press Release, The White House, Office of the Press Secretary, Clinton Administration
Agencies Announce Food and Agricultural Biotechnology Initiatives: Strengthening
Science-Based Regulation and Consumer Access to Information, at http://vm.cfsan.fda.
gov/-lrd/whbio53.html (May 3, 2000).
130. Under the FFDCA, consumers are guaranteed to have available the essential
information with which to make decisions about the products they use. See generally
Degnan, supra note 15.
131. The issue of the right to freedom of religion and its relationship to food
labeling is discussed infra, Part IV.A.3.
132. For an overview of the rise of the commercial speech right and how such a
right is viewed with respect to mandatory labeling initiatives, see Caren Schmulen
Sweetland, Note, The Demise of a Workable Commercial Speech Doctrine: Dangers of
Extending First Amendment Protection to Commercial Disclosure Requirements, 76
TEX. L. REv. 471 (1997).
133. See supra text accompanying note 129.
134. See supra text accompanying note 130.
135. U.S. CONST. amend. I; see also discussion infra Part IV.A.3.
136. See supra text accompanying note 1.
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technologies and the resulting products has yet been conducted to
establish that such foods are safe.1 37 While more research could be done
and is ongoing at this time, no scientific reason has arisen to believe that
GM foods are unsafe and should be treated differently from any other
food product. 38  Crucial to this finding is the fact that every food
product contains DNA, 39 or genetic information. Without a showing of
specific hazards, there is no reason to believe that the small genetic
deviations that exist in GM food products would create increased risk.1
4 0
In finding no valid data to the contrary, yet taking some precaution by
requiring heightened review of GM products in general, the FDA's year-
2000 position is consistent with its duty to protect citizens from unsafe
products.1
4 1
2. Right to Make Informed Food Product Choices
Mandatory labeling is currently required to provide consumers with
the ability to choose products based on nutritional content.-42 The
Nutrition Labeling and Education Act of 1990143 requires food products
suppliers to provide particular nutritional information on the label of all
food products to assist consumers in "maintaining healthy dietary
practices."' 44  Key to this legislation was the identification of the
consumer's ability to understand the value of nutritional-content
information and the need for certain members of the population to
137. See supra text accompanying notes 2, 9.
138. See supra text accompanying notes 1, 64.
139. See supra text accompanying note 3 1.
140. The FDA has mandated a consultation process to ensure product safety even
though it has found no scientifically valid risk that exists with GM products in general.
See Press Release, Food and Drug Administration, FDA to Strengthen Pre-Market
Review of Bioengineered Foods, at http:lwww.fda.govlbbsltopicslNEWS/ NEW
00726.html (May 3, 2000). The FDA recognized in its 1992 policy that "[t]he
established practices that plant breeders employ in selecting and developing new
varieties of plants, such as chemical analyses, taste testing, and visual analyses.., have
proven to be reliable for ensuring food safety." See Statement of Policy: Foods Derived
from New Plant Varieties, 57 Fed. Reg. 22,984, 22,988 (May 29, 1992).
141. See Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4706.
4708 (proposed Jan. 18, 2001) (to be codified at 21 C.F.R. pts. 192 & 592); 21 U.S.C. §
393 (1994).
142. The Nutrition Labeling and Education Act of 1990 amended the FFDCA to
require that food products be labeled with various nutritional content information. H.R.
3562, 101st Cong. (1990) (enacted); see 21 U.S.C. §§ 343(q)-(r), 343-1 (1994).
143. H.R. 3562, 101st Cong. (1990) (enacted).
144. 21 U.S.C. § 343(q)(1)(E).
distinguish between food products for health reasons. 45  Unlike GM
foods in general, when compared only to their non-GM counterparts, the
nutritional content of different food products can vary considerably. The
consumer has the right, then, to know the content of food products when
the consumer can effectively use the information to distinguish between
products. 146
The consumer's right to know, however, is limited by the consumer's
capacity to understand and use the information provided. 47  The
information provided on labels in accord with the right to know must
therefore be limited accordingly to include only that information which
is necessary for the individual to make distinctions between products.
48
Also, to avoid an information overload and thus a loss of value in the
information itself,149 the amount of label information must be carefully
monitored. Opponents of GM products argue that the consumer has a
right to know which products were developed using GM technologies by
requiring a "GM" label on each product. 50  A general GM label,
however, would not assist consumers in the same way nutritional labels
have assisted consumers in maintaining healthy diets.
For instance, there is a large risk that consumers would become numb
to the term GM and find no real distinction between products' 51
145. See supra text accompanying note 94.
146. Where no distinction between products exists, labeling that indicates that it
does can be held misleading under the FFDCA. See Dan L. Burk, The Milk Free Zone:
Federal and Local Interests in Regulating Recombinant bST, 22 COLUM. J. ENVTL. L.
227, 254 (1997).
147. See supra text accompanying notes 94-95. When discussing the effectiveness
of warnings in protecting the consumer's right to make accurate judgments of risk from
warning labels, it is important to define the audience and to ensure that label information
is written so that it can be understood. W. Kip Viscusi & Richard J. Zeckhauser, Hazard
Communication: Warnings and Risk, 545 ANNALS AM. ACAD. POL. & SOC. SCi. 106,
110-11 (1996).
148. The presentation of information on a label "can affect how well consumers
process the information contained." Viscusi & Zeckhauser, supra note 147, at 109; see
also Food Labeling; Declaration of Ingredients, 56 Fed. Reg. 28,592, 28,615 (June 21,
1991).
149. "Overwarning and the overuse of [particular] words may, for example, dilute
their importance. If every product in the supermarket carries a hazard warning, no
distinctions will be made." Viscusi & Zeckhauser, supra note 147, at 108; see also Food
Labeling; Declaration of Ingredients, 56 Fed. Reg. at 28,614.
150. See What Are They Hiding, at http://www.gefoodalert.org/html/hiding.htm
(last visited Sept. 25, 2000).
151. See Food Labeling; Declaration of Ingredients, 56 Fed. Reg. at 28,614; supra
text accompanying notes 95, 149. At this time, no difference has been found between
GM food products and their non-GM counterparts, besides a difference in the method of
production. See supra text accompanying note 1. Methods of food processing have
never formed the basis for labeling of products under the FFDCA because the FDA does
not recognize the methods used to produce foods as material elements of the final
product. See Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed.
Reg. 22,984, 22,984 (May 29, 1992). Only where the final product differs in some way
920
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because more than half of the products on consumer shelves would be
required to carry such a label. 152 What may be even worse is that the
"GM" label, which is likely to be interpreted by consumers as a warning,
may be viewed as more important than other more relevant risk
factors. 53 The most important problem with the "GM" label, however, is
that consumers are not well informed as to what GM really means.'54 A
label simply stating that the food is a product of genetic modification
does not carry meaning to the average consumer.'55 In fact, the
consumer will more likely interpret the label to say that unlike other
products on the shelves, GM foods are nutritionally different from other
non-GM products. 156 This type of thinking could lead to a belief that
other non-GM labeled products on the shelves (designed using
traditional cross-breeding technologies for instance) are not generated
using any sort of genetic variation.'57 Such inferences are not accurate
and could serve to mislead consumers rather than properly inform.
Because of this confusion, the "GM" label, without a detailed
from the common variety does the FDA consider labeling a necessity, and e'en in those
cases, it is the material difference that will be noted, not the process that %%as used to
reach that difference in the label. Id. at 22,991.
152. See Barboza, supra note 17, at Al.
153. "As we provide warnings about increasingly tiny hazards, we make it harder
for consumers to notice warnings about the truly consequential ones." Viscusi &
Zeckhauser, supra note 147, at 112.
154. See U.S. Conswner Attitudes Toward Food Biotechnology. at http:itieinfo.
health.org/foodbiotech/survey.htm (last visited July 14, 2000); see also discussion supra
Part I. The FDA is still taking comments to determine how it will define GM to ensure
truthful and nonmisleading use of the term on food labels. See Draft Guidance for
Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been
Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839, 4840 (Jan. 18, 2001).
155. See U.S. Consumer Attitudes Toward Food Biotechnology, at http:ificinfo.
health.org/foodbiotech/survey.htm (ast visited July 14, 2000). Eighty-six percent of
those surveyed in May 2000 agreed with the statement that "Is]imply labeling products
as containing biotech ingredients does not provide enough information." Id.
156. See supra text accompanying note 1 (regarding the FDA's finding that GM
food products are as safe as their non-GM counterpart). The FDA's finding that GM
products in general are safe is based in part upon the fact that no difference in nutritional
content has been found between those GM foods that have been reviewed and their
traditional counterpart. See Press Release, Food and Drug Administration. FDA to
Strengthen Pre-Market Review of Bioengineered Foods, at http'Jlwavw.fda.gov/bbs/
topics/NEWS/NEW00726.html (May 3. 2000).
157. Such an argument was posed concerning rbST labeling as well. See Burk.
supra note 146, at 269. A general "contains rbST- label "may incorrectly suggest some
health or nutritional difference" which would be "misleading by suggesting that the
presence of bST is unusual or worth noting." Id.
explanation 58 of scientific technologies, may be inherently misleading
and would therefore violate the FFDCA.
59
The consumer's right to know certainly exists where a safety risk has
been identified. 60  This right to be informed of safety risks exists
regardless of the fact that many consumers either do not read labels or
do not understand what the labels say.161 When looking at the GM food
label and an unidentifiable risk factor, however, it is clear that the
consumer's right to know does not include a right to a GM label on food
products-that is, until a safety hazard or nuitritional difference exists to
be noted. Thus, the FDA was justified in finding that the consumer's
right to know does not provide for a right to a "GM" product label. Not
only could the "GM" label be inherently misleading and misunderstood
by the average consumer, but consumers simply do not have a right to
distinguish between products where no real distinction exists. 162
The FDA rightfully chose instead to protect the consumer's right to
know by establishing voluntary guidelines 63 for those food suppliers
that desire to distinguish and market their products on a GM basis. The
FDA cannot restrict valid, lawful, and nonmisleading communications
by banning all GM labeling information.164 However, the FDA does
158. Due to the lack of awareness of the general public as to what the difference is
between GM foods and others, in order for a label to accurately inform it must provide a
significant amount of information. See supra text accompanying note 155. This was the
case in the rbST labeling debate as well. See Interim Guidance on the Voluntary
Labeling of Milk and Milk Products from Cows that Have Not Been Treated with
Recombinant Bovine Somatotropin, 59 Fed. Reg. 6279 (Feb. 10, 1994); see also
discussion infra Part V.A.2.
159. A food is considered "misbranded" under the FFDCA if the label is "false or
misleading." 21 U.S.C. § 343(a) (2000). The FDA is currently requesting public
comment on whether a clarifying statement is necessary to make products labeled "GM
free" or "biotech free" accurate in order to avoid misleading the consumer. See Draft
Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not
Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839, 4840 (Jan. 18,
2001). There is a concern that such "terms would be misleading if they imply that the
food is superior because the food is not bioengineered." Id.
160. See 21 U.S.C. § 393(b)(2)(A) (1994).
161. Not all labeling information is even read by consumers, nor is all information
received properly understood. It has been shown that consumers have trouble
understanding common food label words such as "polyunsaturated fat," "hydrogenated,"
and even "carbohydrates." Viscusi & Zeckhauser, supra note 147, at 110-11.
162. See supra text accompanying notes 1, 146. In other words, a GM tomato is
still a tomato. The final GM product differs from the non-GM tomato only in the way it
was produced, much like a test tube baby differs from other babies only in the way it was
conceived-the resulting human being we call a baby in either case.
163. See Press Release, Food and Drug Administration, FDA to Strengthen Pre-
Market Review of Bioengineered Foods, at http://www.fda.gov/bbs/topicslNEWS
NEW00726.htmi (May 3, 2000).
164. The FDA, like any other regulatory body, must respect the right to freedom of
speech guaranteed under the First Amendment of the Constitution and cannot ban valid
lawful speech without a substantial government interest to protect. See U.S.C §§ 301-95
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have the power to regulate voluntary communications to ensure that only
reliable information reaches consumers. 16 The protection of the consumer's
right to know about GM foods, then, lies in monitoring voluntary
labeling guidelines for accuracy, not in mandating a meaningless
overbroad label. This decision is consistent with other FDA regulations
that have explored when voluntary versus mandatory labeling is
applicable' 66 in relation to the consumer's right to know.
3. Alliance for Bio-Integrity v. Shalala 6'---The Right to
Freedom of Religion
The right to be free from government interference in the exercise of
one's religion68 can be important when considering the right to make
informed food choices. The "Kosher" food label, for example, has been
the topic of recent review under the constitutional right to religion. 169 In
Commack Self-Service Kosher Meats, Inc. v. Rubin, 1 0 a New York
statute was deemed unconstitutional because the labeling guidelines to
be enforced by the State of New York required the state to apply
"religious authority and interpretation."' 71 This requirement was deemed
an "excessive entanglement and advance[ment of] religion."'" In
reaching its conclusion, the Commack court applied the "three-pronged
Lemon test,1173 under which a challenged law must:
(1) "have a secular purpose" r and therefore not be "'motivated
(1994); Central Hudson Gas & Elec. Corp. v. Pub. Semv. Comm'n of New York. 447
U.S. 557 (1980).
165. In fact, the FDA has an obligation to do so under the FFDCA. See 21 U.S.C. §
343 (1994).
166. See supra text accompanying notes 94-96. Mandatory labeling has been
reserved for those cases where the benefits outweigh the rights of food suppliers-
evidenced by the nutritional content labeling requirements-and for those cases where
the public safety is at risk-evidenced by the general provisions of the FFDCA that
focus on a review of product safety. Voluntary labeling guidelines have been reserved to
ensure accurate commercial communications in cases where mandatory labeling is not
warranted. See discussion infra Parts IV.B.1, V.A.1.
167. Alliance forBio-Integrity v. Shalala, 116 F. Supp. 2d. 166 (D.D.C. 2000).
168. The right is guaranteed by the First Amendment of the U.S. Constitution. U.S.
CONsT. amend. L
169. See Commack Self-Service Kosher Meats, Inc. v. Rubin, 106 F. Supp. 2d 445
(E.D.N.Y. July 28, 2000).
170. Id.
171. Id. at 456.
172. Id.
173. Id. at 452 (citing Lemon v. Kurtzman, 403 U.S. 602, 612 (197 1)).
174. Id. (quoting Lemon v. Kurtzman, 403 U.S. at 612).
wholly by religious considerations,"
' 175
(2) "have a primary effect that neither advances nor inhibits
religion, and
(3) not [] foster excessive state entanglement with religion.' 76
By defining Kosher as food "prepared in accordance with orthodox
Hebrew religious requirements"' 7 7 and by requiring officials to punish
the plaintiff for not adhering to those regulations properly, 78 the court
determined that the state law violated all three prongs of the Lemon
test.179 Under this interpretation of the Lemon test, states may not
establish regulations that involve "monitoring [] the compliance of
vendors"'180 according to guidelines that require the application of a "set
of religious dietary laws."'
8' 1
The issue of the right to religion and GM food labeling was presented
to the U.S. District Court of the District of Columbia in Alliance for Bio-
Integrity v. Shalala. 82 The plaintiff claimed that, by failing to mandate
labeling, the FDA violated the First Amendment rights of consumers to
the free exercise of religion.' 83 The court rejected the plaintiffs religious
claims. 184 Although the court did not apply the Lemon test 85 per se, its
decision can be validated by looking at this test and the analysis
provided under Commack.
Because the FDA has found no valid risk inherent in GM foods, the
FDA has no valid governmental interest to protect. Thus, to mandate
labeling to protect religious dietary preferences would solely derive from
"religious considerations,"'' 86 which is not a proper purpose for a law
under Lemon.' 87 Also, as in Commack, to mandate labeling in accord
with religious dietary preferences would require the FDA to interpret
175. Id. at 453 (quoting Lynch v. Donnelly, 465 U.S. 668, 680 (1984)).
176. Id. at 452-53 (citing Lemon v. Kurtzman, 403 U.S. at 612-13).
177. Id. at 449.
178. See id. at 448.
179. Id. at 454.
180. Id.
181. Id.
182. 116 F. Supp. 2d 166, 170 (D.D.C. 2000). The suit also claims that GM foods
should be treated as food additives and challenges the finding of the FDA that GM foods
are "generally recognized as safe" and therefore not considered food additives and
subject to regulation under the food additive standards of the FFDCA. /d. Plaintiffs
raised two religious challenges: the first, claiming that the FDA's decision not to mandate
labeling of GM products violates the Free Exercise Clause; and the second, claiming that
the FDA's decision violated the Religious Freedom Restoration Act. Id.
183. Id.
184. Id. at 180-81.
185. Lemon v. Kurtzman, 403 U.S. 602 (1971).
186. Rubin, 106 F. Supp. 2d at 453.
187. Id.
924
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religious principles and to advance religion,'8' thereby fostering an
excessive entanglement between states and religion which violates the
Establishment Clause of the First Amendment.' For these reasons, the
Alliance for Bio-Integrity religious freedom challenge fails under standard
Establishment Clause jurisprudence.'90
Plaintiffs in Alliance for Bio-Integrity also raised a challenge to the
FDA's decision under the Religious Freedom Restoration Act
(RFRA).19l The court declared that the FDA was subject to the RFRA
but that the plaintiff failed to establish a violation because the plaintiff
was unable to show that the FDA regulation "substantially burdened
Plaintiffs' religion."' 92 The court determined that a substantial burden
cannot arise simply because the FDA refuses to "take action to further
the practice of individuals' religion.' ' t93 In rejecting the RFRA claim,
the court went further, saying that if the FDA did mandate action, it
would come "close to violating the First Amendment's Establishment
Clause."' 94 The inconvenience alleged by the plaintiff was not enough
to mandate action by the FDA to protect the right to religious dietary
preferences.195
One's right to freedom of religion, unless substantially burdened by
government action, is not alone sufficient to give the FDA the power to
mandate that food suppliers inform consumers about the use of genetic196
techniques in food production.' Voluntary labeling guidelines based
188. See id. at 456.
189. See id. at 459; see also U.S. CONsT. amend. 1.
190. The court in Alliance for Bio-Integrity held that the challenge regarding the
right to free exercise of religion was not valid because the FDA's policy was neutral with
respect to religion. Even if some burden to exists to the plaintiff, the court determined,
as long as the FDA policy is neutral, it does not violate the plaintiffs First Amendment
rights. Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166, 179--0 (D.D.C.
2000).
191. 42 U.S.C. §§ 2000bb-bb-4 (1994).
192. Alliancefor Bio-Integrity. 116 F. Supp. 2d at 180-81.
193. Id. at 180.
194. Id. This is similar to what the court held in Commnnack when looking at state
legislation that required application of religious principles. See Commack Self-Service
Kosher Meats, Inc. v. Rubin, 106 F. Supp. 2d 445, 458 (E.D.N.Y. 2000).
195. "While the Court recognizes the potential inconvenience the lack of labeling
presents for Plaintiffs, Defendant's decision [not] to mandate labeling of genetically
modified foods does not 'substantially' burden Plaintiffs' religious beliefs." Alliance for
Bio-Integrity, 116 F. Supp. 2d. at 181. "In this case, the Plaintiffs' liberty is not
restricted and they are free to choose their food and may obtain their food from the
source of their choosing." Id.
196. See id at 180-81; see also discussion hifra Part IV.B.I.
on objective, nonreligious standards are more likely to be the source of
protection of the consumer's right to freedom of religious dietary
considerations.' 97 The focus of parties interested in protecting religious
freedoms should, therefore, be on how to distinguish new products under
"traditional" religious methodologies so that those who wish to label
products in accord with those beliefs may be able to do so in a truthful
and nonmisleading manner.
198
B. Rights of the Food Manufacturer or Producer
The rights of the food supplier are crucial to the finding that
mandatory labeling is not appropriate for GM foods. When balancing
the right of the consumer to know about genetic alterations in foods
against the supplier's commercial freedoms of speech' 99 and trade,200
mandatory labeling cannot be found appropriate in this general context.
Some degree of governmental interest is required before interference
with the supplier's rights is justified.20 1  Because no substantial
government interest can be identified concerning GM foods due to the
lack of known risk to the public, the FDA was required to hesitate in
mandating action.
1. Freedom of Commercial Speech
The First Amendment right to freedom of speech incorporates both the
right to speak freely and the right not to be required to speak against
one's will.20 2 Similar principles apply when comparing the freedom to
197. Similar guidelines have been established to monitor "Organic" food labeling.
See generally 7 U.S.C. §§ 6501-6522 (1994); Kenneth C. Amaditz, The Organic Foods
Production Act of 1990 and Its Impending Regulations: A Big Zero For Organic Food?,
52 FoOD & DRUG L.J. 537 (1997); Terence J. Centner & Kyle W. Lathrop,
Differentiating Food Products: Organic Labeling Provisions Facilitate Consumer
Choice, I DRAKE J. AGRIc. L. 30 (1996).
198. Judge Kollar-Kotelly stated, in Alliance for Bio-Integrity, that the Plaintiffs'
religious challenges would be "better directed at Congress" since the FDA did not have
the power under the FFDCA to require action of the sort requested. Alliance for Bio-
Integrity, 116 F. Supp. 2d at 181.
199. See Central Hudson Gas & Elec. Corp. v. Pub. Serv. Comm'n of New York,
447 U.S. 557, 561 (1980) (noting that commercial speech is "expression related solely to
the economic interests of the speaker and its audience").
200. Interstate commerce is protected under the Commerce Clause of the U.S.
Constitution. U.S. CONST. art. I, § 8, cl. 3; see discussion infra Part V.4 (discussing the
potential interference on interstate trade if individual states were to impose differing
mandatory labeling initiatives).
201. This is required under both the constitutional right to freedom of speech and
the right to freedom of trade. See Int'l Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 72
(2d Cir. 1996); Dean Milk Co. v. City of Madison, 340 U.S. 349, 354 (1951).
202. Int'l Dairy Foods Ass'n, 92 F.3d at 71 (citing Wooley v. Maynard, 430 U.S.
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speak with the freedom not to speak . 0 3 Although commercial speech
has been found to deserve less protection than the individual's right to
freedom of speech,7 4 the right to freedom of commercial speech
nonetheless plays heavily into the validation of the FDA's decision not
to require GM food suppliers to speak against their will in the form of
mandatory labeling.20 5
The right of commercial speech is protected under the Central Hudson
Gas & Electric Corp. v. Public Service Comnission of New York four-
part test.206 Regulation of commercial speech is permitted under this test
in cases where:
(1) The speech is [un]lawful and misleading;
(2) A substantial government interest can be identified;
(3) The regulation "directly advances" the asserted interest; and
(4) The regulation is "not more extensive than is necessary to serve
that interest."20 7
Under this four-part test, and in light of the relevant application and
analysis of the right to be free from compelled speech discussed in
International Dairy Foods Association v. Amestoy, 25 the FDA decision
not to mandate labeling is appropriate. In International Dairy Foods,
the circuit court reviewed the constitutionality of a Vermont State law
mandating labeling of biotechnology-enhanced milk.' °9 The court ruled
that the state of Vermont had not established a substantial government
interest210 because the reason for the statute consisted merely of a
"strong consumer interest and the public's 'right to know."' 21' Thus,
705,714 (1977)).
203. See id. at 72.
204. Central Hudson Gas & Elec. Corp., 447 U.S. at 562-63.
205. See Int'l Dairy Foods Ass'n, 92 F.3d at 71-73.
206. Central Hudson Gas & Elec. Corp., 447 U.S. at 566. The Central Hudson test
was employed in International Dairy Foods to address a mandatory speech issue in the
same manner as it was applied in Central Hudson to protect against a ban on speech.
Int'l Dairy Foods Ass'n, 92 F.3d at 72.
207. See Central Hudson Gas & Elec. Corp., 447 U.S. at 566. Applying this test in
International Dairy Foods, the court stated. "[V]e must determine: (1) whether the
expression concerns lawful activity and is not misleading; (2) whether the government's
interest is substantial; (3) whether the labeling law directly serves the asserted interest:
and (4) whether the labeling law is no more extensive than necessary." Int'l Dairy
Foods Ass'n, 92 F.3d at 72.
208. See Int'l Dairy Foods Ass'n, 92 F.3d at 71-72.
209. Id. at 69.
210. Id. at 73.
211. Id. (quoting Int'l Dairy Foods Ass'n v. Amestoy, 898 F. Supp 246. 249 (D.Vt
1995)).
under the Central Hudson test, the state did not have the power to
"compel the dairy manufacturers to speak against their will. '212
The lack of government interest stemmed from the fact that no
"scientific evidence" demonstrated that the biotechnology-enhanced milk
product was any different from, or posed any "real" harm to consumers when
compared to the nonenhanced product.2 3  The court determined that
"mere consumer concern is not, in itself, a substantial interest.' 2 4 The
commercial-speech analysis ended at the second prong of the Central
Hudson test when the court discovered no substantial government
interest to protect and therefore no state power to interfere with the right
of product suppliers to be free from compelled communication. 2 1 The
case demonstrates the limits on the power of regulatory bodies like the
FDA to mandate speech under the Central Hudson test and the First
Amendment.
The FDA adhered to the commercial speech guidelines established in
these cases in finding that mandatory labeling is not warranted for GM
foods.216 The FDA was unable to establish a substantial government
interest given the fact that no valid scientific evidence demonstrating any
risk of harm to consumers from GM foods in general now exists.2 1 7 Due
to the rights of farmers and other food product suppliers to be free from
compelled communications and the costs of informing the consumer
where no risk of harm exists, the FDA could not successfully mandate
labeling of GM foods without more.2 18 Mere consumer concern is all
that exists at this time regarding GM foods and under the Central
Hudson test, this concern is not enough to warrant mandatory labeling
212. Id. at 74.
213. Id. at 73. "[A] governmental body seeking to sustain a restriction on commercial
speech must demonstrate that the harms it recites [as part of its government interest] are
real and that its restriction will in fact alleviate them to a material degree." Id. (quoting
Edenfield v. Fane, 507 U.S. 761, 770-71 (1993)). Applying this standard, the court held
that Virginia failed to establish that its interest was substantial because strong consumer
interest alone is not enough to justify a state in restricting a food supplier's constitutional
rights. Id.
214. Id. at 73 n.1.
215. See id. at 73.
216. While the FDA did not address constitutional concerns in its recent decision,
its decision can be validated on First Amendment grounds as discussed infra.
217. See supra text accompanying note 1.
218. See discussion infra Part IV.B.I. "Mandatory labeling of products that contain
GMOs or GMO-derived ingredients essentially imposes all of the costs of labeling on
those.., who are willing to continue to use products containing GMOs." Beales Ill,
supra note 56, at 113. Essentially, the GM opponents seeking mandatory labeling are
looking for "more information than they are willing to pay for." Id. Looking solely at
information costs, then, voluntary labeling is the more efficient solution. Id. "With
voluntary labeling, consumers who value the information are the ones who must pay the
costs associated with it; those who do not care are not burdened with the cost of
information that is of no value to them." Id. at 112-13.
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and a corresponding interference with the First Amendment rights of
food suppliers.
C. Evaluating the Balance for GM Foods-FDA Decision
Finds the Appropriate Balance
In evaluating its power to establish mandatory labeling standards for
GM foods, the FDA has essentially found that the rights of the product
supplier to be free from compelled communication outweigh the limited
rights of the consumer.2 9 The crucial distinguishing factor is the fact
that the risk of harm to the consumer currently consists only of
speculation and a fear of technological progress.Y0 Or maybe it is a fear
by organic food producers that biotechnology may destroy their
businesses by offering pesticide-free foods at a reduced cost. 2 '
Whatever the reason, no evidence currently indicates that GM foods
pose any harm to consumers. Thus, the FDA's authority over food
suppliers is restricted due to a lack of government interest sufficient to
warrant the establishment of mandatory labeling laws.
Neither the consumer's right to safe food products, the right to make
knowledgeable food choices, nor the right to religion are sufficient to
outweigh the interests of the food suppliers to be free from compelled
communications in the case of GM foods. The consumer's right to know
is thus limited in the area of GM food regulation. The consumer's right
to know is not without force, but this right will be better protected under
219. The FDA has been shy to mandate labeling of food products where nothing but
a consumer's desire to know is at stake. See supra text accompanying notes 94-96. 213.
In requiring a safety hazard or other government interest prior to mandating labeling in
the food industry, the FDA must balance the rights of the consumer to enjoy saft food
products and to be informed of food product contents with the rights of the food supplier
to be free from compelled communications and the costs of informing the public of food
product information. See supra text accompanying notes 94-96, 213.
220. See supra text accompanying note 64.
221. Such a theory has recently been suggested. See Douglas R. Johnson, Anti-
Biotech Battle Taking Toll on Maine, at http.//www.bangomews.com/egi-bin/article.
cfrn?storynumber=20372 (Sept. 6, 2000); see also Douglas T. Nelson. Case Against
Biotech Food Has to Do With Conunercialisin, Not Safety, KNIGHT RIDDERITRIB., Sept.
22, 2000, available at LEXIS, News Group File, All. Notice that the Organic
Consumers Association is one of the organizations heading the opposition to GM foods.
See Kreiger, supra note 2, at 1999 WL 28717179. If such a theory is correct, it may be
time to review the history of activity that surrounded the introduction of margarine in a
butter market. For an interesting discussion of this issue, see Geoffrey P. Miller, Public
Choice at the Dawn of the Special Interest State: The Story of Butter anl Margarine. 77
CAL. L. REv. 83 (1989).
voluntary labeling guidelines as opposed to mandatory regulations. 222 These
guidelines will ensure the protection of food suppliers from unnecessarily
bearing the costs of informing an uneducated public about GM foods.223
Granted, many product suppliers will choose to provide labeling
information to consumers if the desire to be informed on the part of
consumers is real. Recognizing this reality, the FDA is currently drafting a
set of voluntary guidelines to ensure that the public is not misled by such
communications.2 24  These voluntary guidelines more appropriately
account for the balance in rights of the two opposing parties in the GM
food-labeling debate.
D. Organic Food-Consumers Have a Non-GM Food Choice
One of the leading opponents of GM food claims that "[clonsumers
want real food and the right to know and to choose., 225 Greenpeace
explains that unpredictable effects, inadequate safety testing, and the
precautionary principle demand that consumers be provided the ability
to choose to avoid GM products.226 As of December 2000,227 consumers
will soon be able to reliably choose to avoid GM foods by deciding to
buy only "organic" products. Because the National Organic Program's
(NOP) new organic guidelines ban the use of genetic engineering in food
processing, consumers will have the ability to avoid GM food
products.228
A decision to buy organic, however, will come at a hefty price since
222. See supra text accompanying notes 6, 105.
223. Although mandatory labeling expenses are avoided, the FDA's proposed
consultation process will cost food suppliers more than twenty thousand dollars to
introduce a new GM food product that is now required to undergo the consultation
process. See Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4706,
4729 (proposed Jan. 18 2001) (to be codified at 21 C.F.R. pts. 192 & 592).
224. See Press Release, Food and Drug Administration, FDA to Strengthen Pre-
Market Review of Bioengineered Foods, at http://www.fda.gov/bbs/topics/NEWS/NEW
00726.html (May 3, 2000).
225. We Want Natural Food!, at http://www.greenpeace.orgl-geneng/structur/food.
htm (last visited Jan. 11, 2001).
226. See, e.g., Genetic Engineering, at http://www.greenpeace.org (last visited Feb.
12, 2001).
227. On December 20, 2000, the USDA announced the release of new standards for
organic products. See Secretary Glickman's Remarks at NOP Press Conference Dec. 20,
2000, at http://www.ams.usda.gov/nop/glickremarks.htm. The standards define "organic"
under a marketing program called the National Organic Program (NOP) developed by
the USDA pursuant to the Organic Food Production Act of 1990. See National Organic
Program Overview, at http://www/ams.usda.gov/nop/facts/overview.htm (Dec. 2000);
Background and History, at http://www.ams.usda.gov/nop/nop2000/nop/background
andhistory2.htm (last visited Feb. 12, 2001); Labeling and Marketing Information, at
http://www.ams.usda.gov/nop/facts/labeling.htm (Dec. 2000).
228. See National Organic Program Overview, at http://www/ams.usda.gov/nop
facts/overview.htm (Dec. 2000).
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organic foods generally cost over fifty-seven percent more than
traditional food products.229 It is important to note that paying the higher
price does not guarantee that organic foods will not one day give rise to
some unpredictable effect; like all food products, no organic food has
ever proven to be one hundred percent free of safety or environmental
hazard.230 In fact, when the NOP was announced, Agriculture Secretary
Dan Glickman clarified the reality of organic foods by saying, "[tihe
organic label is a marketing tool. It is not a statement about food safety.
Nor is 'organic' a value judgment about nutrition or quality."2'
' -
Although the same problems with sorting GM from non-GM products
in the food production process exist - 2 (as exemplified by the recent
Taco Bell taco shell scare), -3 the costs will be borne by the parties that
desire to discriminate between foods that were produced using GM and
those that were not. By placing the costs of the right to know on the
people that truly desire to use such information, (as society has deemed
229. Steven Milloy, Organic Food Seasoned Vith Fear, WAsH. TLmIES, Jan. 2.
2001, at A13, 2001 WL 4143536. Higher organic food costs could lead to S4000 a year
in additional food expenses for a four-member family. Id. Because the organic product
distinction has never been shown to demonstrate an increase in nutrition, quality, or food
product safety, the organic food has been called a "[ripoff." Id.; see also Mary Brophy
Marcus, Organic Foods Offer Peace of Mind-Ar a Price, U.S. NEWs.co.%I. at http.//
www.usnews.comfusnewslissuei0101 15/nycu/organic.htm (Jan. 15, 2001).
230. The public has seen first hand the uncertainty that surrounds various food
products. For example, one day reports say that drinking red wine is recommended and
another day new reports claim that those recommendations have been reconsidered and
may not be accurate. For up-to-date nutritional information and an example of the
confusion that exists with even the most basic foods, see the followving nutritional Web
sites: http://www.nutrition.gov or http://www.nutrinews.com/publiclhealthconcerns/
index.cfm (last visited Jan. 11, 2001).
. 231. Milloy, supra note 229, at A13; see also Secretary Glickman's Remarks at
NOP Press Conference, at http://wwwv.ams.usda.gov/nop/glicknemarks.htm (Dec. 20,
2000).
232. While already being considered, a new regulatory hurdle will arise in how to
manage GM pollution-the possibility that a GM plant will contaminate a non-GM
neighboring crop or create disease resistant pests that cannot later be controlled. See
generally Richard A. Repp, Comment, Biotech Pollution: Assessing Liability for
Genetically Modified Crop Production and Genetic Drift, 36 IDAHo L REV. 585 (2000).
While environmental issues indeed surround the use of GM foods-in the exact same
way that such issues arise with the use of traditional food production methods that have
been used to introduce new plant varieties to ecosystems for hundreds of years-labeling
the final food product for consumer shelves is not a good solution to the problem
because environmental damage would already have been done at that point.
233. Certain Taco Shells were recalled due to an unintended mixture of
nonapproved GM corn with approved GM corn in late 2000. See Kate Devine, GM
Food Debate Gets Spicy: Recalled Taco Shells with Engineered Corn Fuel Controversy,
ScENTsT, Oct. 30, 2000, at 10.
appropriate for organic and Kosher foods for some time), the majority of
the food supply (since the majority contain some sort of genetic
enhancement) will not be threatened with the higher costs that would
arise if all nonorganic foods had to be labeled GM. In other words, it is
more cost effective to label the minority of products GM-free or organic
(according to FDA and USDA guidelines) than to label the majority
GM. Organic foods thus offer the choice to consumers that opponents
claim the consumer right to know and choose demands, again validating
that a broad mandatory label is not necessary nor warranted.
V. INDIVIDUAL STATES MUST CONSIDER ALTERNATIVE LEGISLATIVE
ACTIVITY TO MONITOR GM FOODS
Several states, including California, Colorado, Michigan, Minnesota,
Pennsylvania, and Vermont are currently-or have recently-considered
proposed legislation that would mandate labeling for GM foods.
23
However, even advocates for mandatory labeling do not believe that
these labeling initiatives should be handled on the state level due to the
potential negative impacts on free trade in the United States.235
Accordingly, mandatory labeling legislation has already started to fail on
236the state level. As the appropriate balancing tests are conducted with
regard to GM foods, opponents of GM foods will be forced to consider
alternative forms of regulation.
California, New York, Nebraska, West Virginia and Iowa are already
considering alternative legislation that would limit the sales or
production of GM foods.237 As mandatory labeling legislative bills fall,
additional states are likely to face bills like these to handle GM
concerns. When evaluating such alternatives, states should carefully
review proposed legislation to make sure they base decisions not solely
on consumer fears and political lobbying efforts but upon valid scientific
necessities. States must consider, in addition to a balancing of individual
rights, the issues of federal preemption and potential interference on
interstate commerce as they consider supplemental legislative actions.
234. See supra text accompanying note 13.
235. "[A] national standard for labeling genetically engineered foods established by
the FDA would be preferable to action at the state level." Michael A. Whittaker,
Comment, Reevaluating the Food and Drug Administration's Stand on Labeling
Genetically Engineered Foods, 35 SAN DIEGO L. REv. 1215, 1228 (1998).
236. The California Senate Bill 1513 that would have mandated labeling of GM
products failed passage on August 9, 2000. S.B. 1513, 1999-2000 Reg. Sess. (Cal.
2000). Similar bills in Minnesota, Maine, New Hampshire and Vermont have also
recently failed. See H. 506, 119th Leg., 1st. Reg. Sess. (Me. 1999); H. 3973, 81st. Reg.
Sess. (Minn. 2000); H.B. 1204, 156th Sess. (N.H. 2000); H.B. 794, 1999-2000 Sess. (Vt.
2000).
237. See supra text accompanying note 14.
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A. Balance Should Be Upheld on the State Level-Voluntaly, Not
Mandatory Labeling is the Solution
While most states have already rightly rejected mandatory labeling
efforts in the face of the recent FDA decision, 8 states may again have
similar legislation to consider in the future. Hence, the reasoning behind
the rejection of such proposals becomes important. Some states may
choose to ignore FDA decisions and continue to review mandatory
labeling guidelines.239 However, in so choosing, states run the risk of
developing unconstitutional legislation, as Vermont was found to have
done in International Dair, Foods Association v. Aniestoy. 2 40 States
also run the risk of federal preemption or of placing an undue burden on
interstate commerce if they establish strict voluntary labeling guidelines
which, for example, unnecessarily discriminate between products from
other states.241 To avoid challenge on the grounds of freedom of speech,
federal preemption, or Commerce Clause violations, states will thus be
forced to review the appropriate balance of rights between the consumer
and the food supplier to validate any alternate regulation of GM
products.
1. The International Dairy Foods Association v. Amestoy242 Risk-First
Amendment Rights of Food Suppliers
Although the FDA approved rbST milk for sale and refused to
mandate labeling of this type of milk product, the State of Vermont
enacted a statute requiring the labeling of rbST milk "to help consumers
make informed shopping decisions."243  However, because the milk
supplier's right to be free from compelled speech was not "given the
238. See supra text accompanying note 236.
239. This was the case in Vermont when dealing with the rbST labeling issue. See
Int'l Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 69 (2d Cir. 1996); see also Burk. supra
note 146, at 247.
240. 92 F.3d at 74.
241. See discussion hiifa Part V.A.4.
242. A mandatory labeling law in Vermont was found unconstitutional under the
First Amendment because its only purpose was to protect the consumers desire to know.
Int'l Dairy Foods Ass'n, 92 F.3d at 73-74. The mere "wish to know" %%as found
insufficient to justify infringement of the food producers' First Amendment freedom
from compelled communication. Id. at 74.
243. ld. at 70.
proper weight,'"244 the U.S. Court of Appeals, Second Circuit, determined
that the dairy manufacturers were entitled to an injunction. 245  The
statute, the court held, infringed on the milk supplier's First Amendment
rights.246 Like GM foods in general, no proof existed that rbST milk
posed any additional risk of harm to consumers when compared to
247regular milk. It is this lack of harm that led the court to find the right to
know of the consumer "insufficient to permit the State of Vermont to
compel the dairy manufacturers to speak against their will. '248 The court
noted that interested consumers "should exercise the power of their purses
by buying products from manufacturers who voluntarily reveal it."249
The importance of International Dairy Foods to states reviewing
legislative regulation of GM food products is clear. Simply, states must
consider and weigh the rights of the consumer against the rights of the
food supplier when considering which action to take.250 To lawfully
infringe upon the right to be free from compelled speech, the states must
first identify a valid state interest that deserves protection.25 1 The
consumer's mere "desire" to know is not enough to overcome the right
of the food producer to choose when to speak.252 Protection of this First
Amendment right is important because, if ignored, there would be "no
end to the information that states could require manufacturers to
disclose.,
253
At this time, no real safety risk exists with regard to GM technologies
in food processing and manufacture. 54 Without evidence to the contrary,
and in light of the FDA's finding that GM foods are inherently safe,
states will not likely be able to identify a valid state interest to protect.
Consequently, mandatory labeling appears to be out of the question on
the state level, at least for GM products in general.
Unlike mandatory labeling, a state does have a valid interest to protect
244. Id. at 71.
245. Id. at 74.
246. See id.
247. For a detailed discussion about the FDA's safety findings for rbST milk and
how its decision not to label such products should be reviewed, see Burk, supra note
146, at 254.
248. Int'l Dairy Foods Ass'n, 92 F.3d at 74.
249. Id.
250. See discussion supra Part IV.B.1. States are likely to see guidelines posed by
the FDA concerning voluntary labeling of GM foods which are similar to those provided
by the FDA concerning the rbST label. See Interim Guidance on the Voluntary Labeling
of Milk and Milk Products from Cows that Have Not Been Treated with Recombinant
Bovine Somatotropin, 59 Fed. Reg. 6279 (Feb. 10, 1994).
251. See discussion, supra Part IV.B. 1 (discussing the Central Hudson test).
252. Int'l Dairy Foods Ass'n, 92 F.3d at 74.
253. Id.
254. See supra text accompanying note I.
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when reviewing GM information that is voluntarily placed on labels. 
5
States have an interest in protecting their consumers from misleading or
false communications2 6 States can thus exercise the right to review
voluntary communications aimed at consumers by developing reasonable
guidelines by which to monitor those communications.
2. Other Lessons from rbST-Appropriate State Action for Dealing with
Voluntary Labeling Initiatives
After finding that rbST milk products were as safe as other milk products
and therefore that no mandatory labeling scheme was appropriate for
rbST milk products, the FDA provided recommendations to the states on
how to best pursue voluntary labeling initiatives on the local level?2 '€ In
handling the rbST debate, the FDA noted that it would "rely primarily
on the enforcement activities of the interested States to ensure that rbST
labeling claims are truthful and not misleading." s Because all milk
products contain natural bST, a simple "bST-free"- 9 label could imply a
difference between milk products and was therefore found to have the
potential to mislead consumers without more information.260 Thus, the
FDA determined that to provide accurate labels to consumers, additional
information would be required to put the statement "in a proper contextf
2 6'
and assure that labels are properly understood.262 The FDA recommended
that states consider the "complete label"2 63 and any "[a]vailable data on
255. As the FFDCA mandates, the FDA has a valid interest to protect citizens from
false and misleading labeling. See 21 U.S.C. § 343 (1994). This interest can be
protected most efficiently under the police powers of each state. See Burk. supra note
146, at 249.
256. See 21 U.S.C. § 343.
257. See Interim Guidance on the Voluntary Labeling of Milk and Milk Products
from Cows that Have Not Been Treated with Recombinant Bovine Somatotropin. 59
Fed. Reg. 6279 (Feb. 10, 1994).
258. Id. at 6280. When reviewing food products shipped in interstate commerce.
FFDCA section 403(a), requiring labeling to be truthful and not misleading, requires the




262. The FDA suggested, for example, that states require, in addition to a label
claiming that the milk was "from cows not treated with rbST," that it also say that "[nol
significant difference has been shown between milk derived from rbST-treated and non-
rbST-treated cows." Id. Listing the commercial purpose for not using rbST was also a
recommended way to provide proper context to the label and give it meaning to the
consumer. Id.
263. Id.
consumers' perceptions of the label' '264 when considering appropriate
labeling guidelines.
Due to the similarities between the FDA's findings regarding GM
foods and rbST milk products, the states are likely to see similar
guidelines for dealing with voluntary GM food labeling.265 States, then,
that wish to protect the consumer's right to know about GM foods
should consider appropriate voluntary labeling guidelines. The more
challenging portion of developing such guidelines pertaining to GM
foods lies with the FDA suggestion that states also consider how to
establish the validity of labeling claims as part of voluntary labeling
initiatives.
26 6
Like GM foods in general, when compared to each GM food's
traditional counterpart, no identifiable "compositional differences" exist
between rbST derived milk and non-rbST derived milk.267 Therefore, to
ensure that labeling is truthful and that "bst-free" claims are accurate, the
FDA recommended that states establish record-keeping guidelines for
food suppliers and develop inspection procedures under the state's
police power.268 The FDA also suggested that states adopt a certification
program to track the use of rbST and to segregate rbST milk from non-
rbST milk.269
In the face of concerns over the ability to distinguish GM products
from non-GM products and the reality that some food suppliers may
choose to market their products as non-GM, states should begin addressing
GM foods by developing methods to ensure that voluntary labeling
communications contain accurate information. Therefore, states could
begin by establishing task forces to research consumer perceptions of the
"GM" label and how best to provide a truthful and nonmisleading label
to consumers that wish to know about GM use in food products. In so
doing, as lessons from the rbST guidelines show, states will also have to
focus on establishing methods to validate the accuracy of voluntary
264. Id.
265. The FDA is still "soliciting comments" on its voluntary labeling "guidance
document" for GM food products. Draft Guidance for Industry: Voluntary Labeling
Indicating Whether Foods Have or Have Not Been Developed Using Bioenginecring;
Availability, 66 Fed. Reg. 4839, 4840 (Jan. 18, 2001).
266. See Interim Guidance on the Voluntary Labeling of Milk and Milk Products
from Cows that Have Not Been Treated with Recombinant Bovine Somatotropin, 59
Fed. Reg. at 6280.
267. Id.
268. "States could require that firms that use such claims establish a plan and
maintain records to substantiate the claims, and make those records available for
inspection by regulatory officials." Id.
269. Id. The FDA claimed that its suggestions "would be necessary not because of
any safety concerns about milk from treated cows but to ensure that the labeling of the
milk is not false or misleading." Id.
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labels. These methods may include: (1) defining inspection guidelines for
regulatory officials, (2) mandating record-keeping procedures for food
suppliers, and (3) establishing certification programs for particular GM
food products.
3. Federal Preemption
Although the FFDCA generally does not contain express preemption
guidelines, 270 the risk that state legislation will be deemed preempted by
the FFDCA is real. 271 Federal preemption is mandated when "Congress
intended to occupy" the particular field of legislation, or when state
legislation "actually conflict[s]" with federal legislation.-- In Grocery
Manufacturers of America, hic v. Gerace,27 3 for example, a New York
statute that required the labeling of a particular cheese as an "imitation"
was held preempted by the FFDCA.274  The court determined that
complying with the New York statute actually resulted in creating a
"misbranded" product, which was a violation of the FFDCA and
therefore in actual conflict with the FFDCA.27"
States must therefore carefully consider any regulation in light of the
federal regulations contained in the FFDCA to avoid the possibility that
state legislative acts will later be preempted by federal law. This risk
definitely exists with any sort of mandatory "GM" labeling policy. An
actual conflict would exist between the states' mandate and the FFDCA,
which specifically rejects such a regulation. Voluntary labeling
guidelines, again, are an acceptable solution, but must not result in
misleading or false communications under the FFDCA.276 Defining
appropriate voluntary labeling guidelines will therefore require careful
consideration by individual states that choose to enact labeling
regulations in addition to those prescribed by the FDA. GM food
concerns do not warrant emergency legislation or legislation designed in
270. 21 U.S.C. §§ 301-95 (1994). But an express preemption clause was recently
added to the FFDCA under the Nutritional Labeling and Education Act of 1990 to apply
to nutritional labeling regulations. See 21 U.S.C. § 343-1 (1994). For a more detailed
discussion of preemption and the FFDCA, see Burk, supra note 146, at 249-75.
271. See Grocery Mfrs. of Am., Inc. v. Gerace, 755 F.2d 993 (2d Cir. 1985).
Comm. for Accurate Labeling & Mktg. v. Brownback, 665 F. Supp. 880 (D. Kan. 1987).
272. Grocery Mfrs. of Am., 755 F.2d at 999.
273. 755 F.2d 993 (2d Cir. 1985).
274. Id. at 1003.
275. Id. at 1001.
276. 21 U.S.C. § 343 (1994).
haste. Rather, states must take the time to account for scientific realities
and the guidelines established by the FDA when considering which steps
to take.
4. Interstate Commerce
State laws concerning GM products must be carefully designed so as
not to unnecessarily interefere with interstate commerce. The protection
afforded by the Commerce Clause requires that "'one state in its
dealings with another [does] not place itself in a position of economic
isolation.' 277  Thus, the protection of the Commerce Clause limits
"preferential trade., 278 Where a valid interest in protecting local health
exists, however, states may be justified in regulating products sold
within their borders as long as the method adopted is reasonable.279
Regulations that place restrictions on the sale of GM products in
individual states pose the risk of placing an unnecessary burden on
interstate commerce. This risk is especially apparent with voluntary
state labeling guidelines that may vary from state to state. Multistate
variations, like those that would arise if each state developed differing
labeling guidelines, stand to make it more difficult for product suppliers
to sell products in some states as compared to others.280 If regulations
result in creating "preferential trade areas"28' then, such state regulations
may violate the Commerce Clause and the rights of suppliers to be free
to trade in all states. This concern has led some to find that it would be
preferable for all states to adhere to one set of guidelines provided by the
FDA as opposed to encouraging states to establish individual sets of
rules.282
States do have the power to protect the interests of their citizens by
expanding on legislation provided at the federal level so long as no
actual conflict arises.283 With regard to GM food labeling, the real issue
again will become whether the states have a real interest to protect
277. See Dean Milk Co. v. City of Madison, 340 U.S. 349, 356 (1951) (quoting
Baldwin v. Seelig, Inc., 294 U.S. 511, 527 (1935)).
278. Id.
279. See id. at 354. The Dean Milk court found that "if reasonable nondiscriminatory
alternatives, adequate to conserve legitimate local interests" exist, than such alternative
forms of regulation must be used. Id.
280. See supra text accompanying note 18.
281. Dean Milk Co., 340 U.S. at 356.
282. See Whittaker, supra note 235, at 1228; see also Burk, supra note 146, at 273-
74. "Th[e] national interests in facilitating interstate commerce and in providing the
highest quality goods at the lowest prices would seem to dictate the desirability of
uniform labeling on a national scale... Th[is] argument is strongest where the state
scheme interferes with an FDA requirement." Id. at 274.
283. See Grocery Mfrs. of Am., Inc. v. Gerace, 755 F.2d 993, 999 (2d Cir. 1985).
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considering the lack of scientifically based evidence that such products
differ from the foods currently on consumer shelves.?'s Regulations that
affect interstate commerce and place any discriminatory burden on such
commerce must be validated by an identifiable state interest. The most
commonly recognized state interest is the protection of consumer health.
A city ordinance was struck down in Dean Milk Co. %,. City of
Madison,s8 for instance, when the court ruled that the "regulation [was]
not essential for the protection of local health interests. ' ' 8" The
ordinance established specific guidelines for the type of milk that could
be sold in the locality 7 thereby restricting the level of competition from
outside the state. The court held that the ordinance "erect[ed] an
economic barrier protecting a major local industry against competition"8
and that the regulation could not stand because it created an "undue
burden on interstate commerce."28
9
When considering state-level regulation of GM foods, care must be
taken to ensure that interstate commerce is not unnecessarily affected by
the legislative act. A valid state interest must first exist prior to the
development of legislation. Secondly, state action should attempt to be
consistent with regulations adopted by other states so as not to create an
"economic barrier" to those food suppliers that may not be able to
comply with strict regulations that differ from state to state.9 By using
sound scientific analysis in determining what action to take, states are
likely to employ consistent regulations that do not inhibit interstate
trade.
State mandatory GM labeling initiatives would likely fall in the face
of a Commerce Clause challenge simply because no valid state interest
in consumer health currently exists. However, if product suppliers
choose to include GM information on labels, the issues that surround
284. See supra text accompanying note I.
285. Dean Milk Co., 340 U.S. at 356.
286. Id.
287. Id. at 350.
288. Id. at 354.
289. Id. at 353.
290. "Complying with a multitude of state labeling requirements in order to ship
goods throughout the country would be at best burdensome and at worst physically
impossible." Burk, supra note 146, at 273-74. Increased costs due to conflicting
requirements could cause producers to "simply cease to sell in that jurisdiction." Id.
This is a problem that states should seek to avoid in order to ensure that consumers have
access to a variety of products and the ability to exercise their right to choose between
products.
state regulatory power are different.29' With an identifiable state
interest-protecting consumers from misleading food labels-states
may, using reasonable means, monitor voluntary commercial
communications without being subject to a charge of violating the
Commerce Clause.292  This is because a state interest in protecting
citizens from misleading advertising and labeling probably outweighs
any potential burden it places on interstate commerce, provided that the
state considers the burden it places on food suppliers when selecting a
method to monitor such communications.293
The possibility of First Amendment, Commerce Clause, and federal
preemption challenges will require states to account for the rights of the
food suppliers when devising means to protect the consumer's right to
know about GM foods. When balancing the consumer's right to know
with the rights of the food supplier, states will be forced to consider
solutions other than mandatory labeling, like the FDA has rightfully
done, to address the GM labeling debate on a local level.
VI. RECOMMENDATIONS FOR A SMOOTH TRANSITION FROM CONSUMER
FEAR TO CONSUMER SATISFACTION vITH GM FOODS
Taking into account the recent FDA decision, a solution to the GM
food debate must address the concerns of the public without relying on
mandatory labeling. Dealing with consumer fears is in the best interest
of all parties including, in addition to the individual consumer,
environmentalists, biotechnology companies, and food suppliers.
Consumer fears have thus far only put a hold on technological
advancement that is harmful on all fronts. The Biotechnology Industry
Organization2 94 has instituted a national educational effort to calm those
fears, which is a good first step towards making progress on this
sensitive issue without requiring the drastic step of mandatory labeling.
The following discussion suggests goals with which to focus efforts to
deal with GM foods that may be appropriate for review on the state
level. Compromise based solutions designed to provide consumers with
relevant knowledge and to protect the food supplier from unreasonable
increased costs of doing business through unnecessary labeling
initiatives are also suggested.
291. See discussion supra Part V.A.2.
292. See Dean Milk Co., 340 U.S. at 354.
293. See supra text accompanying note 213.
294. Several biotechnology companies recently joined forces to establish a
marketing campaign in support of bioengineered foods designed to focus on positive
advertising and consumer education. See Albright, supra note 57, at C2.
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A. Goals
Following is a nonexclusive list of goals that states should apply when
reviewing new initiatives that serve to complement the FDA's recent
GM food policy announcement. Alternative actions, designed to offer
greater protection to the consumer's limited right to know, should focus
on:
(1) Reasonable GM food product safety testing, not mandatory
labeling;
(2) Expanded GM food consumer education programs;
(3) Global and interstate harmony based on scientifically sound
GM food regulations; and
(4) Managing and maintaining reasonable food costs and supply.
With these objectives in mind, states should focus on generating a
nonlabeling method to provide general information about GM food
products to respect the consumer's limited right to know. In addition,
states should closely review the voluntary labeling guidelines established
by the FDA and adopt consistent requirements to protect their citizens
from misleading food labels. Finally, states should utilize their
resources to develop specific, yet reasonable, testing guidelines for GM
food products to ensure the safety of the products produced within their
borders.295
B. Possible Solutions
No two GM food products are alike. Just like a carrot is not a banana,
and a GM tomato is not a GM squash, one broad label is not the answer
to calming consumer fears or protecting consumers from any risk that
may exist according to opponents of GM foods in general. Each GM
product deserves its own review, and corresponding state regulations
should be designed to offer flexibility in dealing with a variety of
product types. Accordingly, states should focus legislative efforts only
on those particular GM products suitable for regulation.
Understandably, states will want to explore different options in light
of the public fire that has been raging against GM foods over the last
several years. When considering alternative actions, which must be
295. It is ultimately the food producer's responsibility to ensure product safety and
to engage in a consultation process with the FDA prior to offering its products for sale in
the United States. See Statement of Policy: Foods Derived from New Plant Varieties, 57
Fed. Reg. 22,984, 22,985 (May 29, 1992).
consistent with the FDA's expressed position, the states should take
special care to consider the four goals described above. Regulations
must not be designed to impede scientific progress for fear of the
unexpected, but should be focused on scientifically valid purposes and
rationales.
Of course, where any valid safety risk is identified in a GM product,
more options for state regulation exist. States could rightfully remove
such products from consumer shelves or utilize a risk-benefit analysis,
like that employed by the EPA when evaluating pesticide use in food
production,2 96 to determine if the product should merely be labeled for
consumer awareness and personal risk analysis. Under the current
findings of the FDA, however, GM foods in general do not pose any risk
of harm to consumers.297 Thus, actions in response to GM products
already deemed safe should take into account and recognize this
scientific finding.
2 98
1. Consumer Education and Educational Campaigns
Labeling is not the only way to provide information to a consumer
about the food he eats.2 99 Especially in the age of information, consumers
expect to gain access to information through a variety of mediums.
States could focus efforts to appease the consumer's desire to know
about GM foods by establishing educational advertising programs using
the media, Web sites, toll-free numbers, informational campaign programs
in grocery stores, or by providing incentives for food suppliers and
manufacturers to voluntarily provide such information to consumers.
Developing an educational campaign for GM foods is not likely to be
a simple task due to the uncertainty that exists, even among the scientific
community, regarding how to distinguish one GM product from
another.3" States should focus first on establishing and defining what a
296. When evaluating pesticide use in food products and corresponding labeling
guidelines, the EPA applies a balancing test much like that posed in this Comment to
validate the FDA's decision to adopt voluntary labeling guidelines as opposed to
mandatory guidelines. See 7 U.S.C. § 136 (1994). For a general discussion of the
regulation of pesticide residue labeling, see James Smart, All the Stars in the Heavens
Were in the Right Places: The Passage of the Food Quality Protection Act of 1996, 17
STAN. ENVTL. L.J. 273, 277-79 (1998).
297. See supra text accompanying note 1.
298. See discussion supra Part V (establishing that states run several risks when
adopting scientifically unsound legislation).
299. For a general discussion about effective "hazard communication systemis],"
see Viscusi & Zeckhauser, supra note 147, at 109.
300. See supra text accompanying note 18. The FDA is still not certain how to
correctly distinguish between GM and non-GM food products in a truthful and
nonmisleading manner. See Draft Guidance for Industry; Voluntary Labeling Indicating
Whether Foods Have or Have Not Been Developed Using Bioengineering; Availability,
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GM food is and consider how it differs from other foods. The audience
must then be defined in order to develop an effective educational
campaign. 30 1 Some consumers, for instance, are more sophisticated than
others. 2 Care must be taken to deliver a message that is understandable
and one that does not create excessive alarm among consumers. 30
Granted, developing such an informational campaign will involve more
work than simply mandating a general overbroad label. However, in
light of the realities of GM food, nonlabeling methods of communication
are a better approach if the consumer's desire to know about GM foods
is to be sufficiently addressed.
States could avoid individual state campaigns by focusing on a one-
stop information source, like the FDA, for information on GM foods.
Under the FFDCA, the FDA is already required to provide information
to consumers 3°4 and currently makes available all safety testing information
for the GM products it has reviewed.3 05  The Biotechnology Industry
Organization has already launched a national educational campaign
about the merits of GM technologies306 on behalf of the scientific
community, which may further relieve states of the obligation to do so.
While it is important to inform the consumer about the scientific
realities of GM technologies in food production, it is also important to
address the moral-emotional "outrage" that has separated the opponents
of GM from the scientific proponents of GM.30 7 Instead of focusing only
66 Fed. Reg. 4839, 4840 (Jan. 18, 2001).
301. See Viscusi & Zeckhauser, supra note 147, at 109.
302. Id.
303. "Overwarning introduces dangers. If we exaggerate modest risks, we will
have no credible mechanism for alerting people to greater hazards." Id. at 109-10.
304. The FDA is required to "conduct[ ] educational and public inform.ation
programs relating to the responsibilities of" the FDA. 21 U.S.C. § 393 (d)(2)D) (1994).
305. In its May 2000 announcement, the FDA has agreed to provide all necessary
information to consumers concerning GM foods on its Web site. See Press Release.
Food and Drug Administration, FDA to Strengthen Pre-Market Review of Bioengineered
Foods, at http://www.fda.govibbs/topics/NEWS/NEWO0726.html (May 3. 2000). Public
disclosure is clearly a priority under tne FDA's new policy. See Premarket Notice
Concerning Bioengineered Foods, 66 Fed. Reg. 4706, 4714 (proposed Jan. 18, 2001)1 to
be codified at 21 C.F.R. pts. 192 & 592). "In light of the significant public interest in
bioengineered foods," the FDA plans to disclose the fact that a food developer is
engaged in the consultation process as well as the data and information provided unless
the manufacturer establishes that such information is confidential in nature. Id.
306. See supra text accompanying note 294.
307. Peter M. Sandman, Two-Way Environmental Education, at http/JAwww.
psandman.comlarticles/informing.htm (ast modified Apr. 2000). Environmental risk has
been classified into two groups, 1) "hazard," or the technical facts and data portion of a
on consumer education concerning the scientific background of GM
technologies, it has been suggested that a proper risk communication
program will also include serious consideration and debate about the
social and moral issues that are more likely to be the source of consumer
fear.30 8 Six tips have been identified for developing a communication
campaign about controversial risks: [1] Don't keep secrets . . . , [2]
Listen to people's concerns . . . . [3] Share power (give communities
more control over the risks) ... , [4] Don't expect to be trusted. Instead
of trust, aim at accountability .... [5] Acknowledge errors . . . , and
[6] Treat adversaries with respect.
' 309
The need for proper education programs that inform the consumer of
the benefits of GM technologies in the food market cannot be
underestimated. It has been suggested that the reason the public is
alarmed about GM foods as compared to GM drug products created
using the same genetic techniques yet filling consumer shelves with no
indication of concern, is that the benefits of a drug are obvious whereas
the benefits of GM in food production are not.3 '0 The benefits of GM
technologies, for instance, are more easily recognized by farmers or
animal breeders-those that see first hand the increased product yields
GM may offer, those fighting to save their crops or animals from disease
and pests, and those that see the effect of farming or grazing on the soil
and water surrounding the farm land. Consumers, on the other hand, are
likely to see the benefits of GM only as a decrease in cost, and this is not
an obvious benefit. By adding a focus on the benefits of GM to an
educational campaign, while also addressing the potential risks that
exist, people may be more confident that both have been taken into
debate and 2) "outrage" which focuses on the moral-emotional portion of a debate. Id.
"The public is preoccupied far more with outrage than with hazard. The engine that
propels the fight over safe-versus-dangerous, in other words, is good-versus-evil." Id.
Thus, taking into account the key issues of outrage-who benefits from a new
technology, who controls the use of such a technology, whether those in charge are
trustworthy, whether the public had a choice or a voice in adopting the new technology,
and finally whether those in charge respond effectively and with respect to the concerns
raised-is a good way to begin evaluating a potential GM food informational campaign.
Id.; see also Peter M. Sandman, Risk Communication: Facing Public Outrage, at http://
www.psandman.comlarticles/facing.htm (last modified Apr. 2000).
308. Peter M. Sandman, Risk Communication, at http://www.psandman.coml
articles/riskcomm.htm (last updated Apr. 2000).
309. Id.
310. See Peter A. Singer & Abdallah S. Daar, Avoiding Frankendrugs, 18 NATURE
BIOTECHNOLOGY 1225 (2000). "[G]enetically engineered drugs, like recombinant human
insulin, have been used without controversy, [and], for life-saving drugs at least, the
public clearly perceives that their benefits far outweigh any risks." Id. It has been
suggested that GM pharmaceutical companies should heed the lessons learned from the
GM food debate; GM pharmaceutical manufacturers should therefore inform the public
of the benefits of using new GM techniques and take consumer concerns seriously. Id,
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account thereby reducing anxiety over GM foods in general.
2. Voluntaq' Labeling Guidelines
Like the FDA, individual states should focus their efforts on
establishing reasonable voluntary labeling guidelines. Non-GM food
suppliers are likely to attempt to promote their foods by labeling their
products to instill unnecessary fear on the part of consumers against GM
foods. Labeling of products as "non-GM" will require just as much
review as the labeling of products as "GM" under voluntary guidelines
to avoid misleading the public. 3t' Challenges in the future are likely to
center around making a distinction between GM and non-GM products
and identifying the degree of information required for disclosure to
avoid misrepresentations to the public.
States may always require more regulation at the state level than exists
at the federal level so long as it does not conflict with federal regulation
or inhibit interstate commerce.12 States may therefore require more
extensive testing or differing standards for review under the voluntary
labeling guidelines as long as a substantial state interest is involved.
Establishing voluntary labeling guidelines, research campaigns, or
certification programs to track the whereabouts of GM foods may thus
be the only appropriate form of legislative activity at the state level in
light of the little to nonexistent health concern with current GM food
products.
311. This is precisely the focus of current FDA efforts in creating appropriate
voluntary labeling guidance to manufacturers. See Draft Guidance for Industry:
Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using
Bioengineering; Availability, 66 Fed. Reg. 4839, 4840 (Jan. 18, 2001). For a general
discussion of similar issues in relation to rbST voluntary labeling, see Burk. supra note
146, at 268-75; see also discussion supra Part V.A.2. Defining "GM" foods is the
problem: it will require a system not only to segregate GM from non-GM food products,
but will require a precise definition of what GM is. For example, guidelines need to be
established defining what level of genetic modification used in the final product will lead
to the designation GM. Standards, like those established for organic foods, will have to
be developed before GM or non-GM designations will be accurate and not misleading.
For a review of standards established for organic food labeling, see sources cited supra
note 197.
312 See discussion supra Part V.A.3-4.
3. Establish Testing and Research Programs-A Review of
California Legislative Activity and Its Food
Biotechnology Task Force Solution
Because the real concern over GM foods lies in a dissatisfaction with
product safety testing and a fear of the unexpected, states can focus on
calming consumer fears by establishing task forces or committees to
study GM technologies and the foods they produce. The California
legislature has just adopted legislation that creates a Food Biotechnology
Task Force to handle GM concerns in a sound scientific manner. 3 The
amendment to the California Food and Agricultural Code was designed
with a recognition of the federal regulatory framework and the need to
review this framework when establishing the role California should play
in the regulation of GM food products.
314
The bill lists several factors that the Task Force would be responsible
for evaluating, demonstrating that the California legislature is taking into
account federal preemption, the effects on interstate commerce, consumer
safety, and potential voluntary labeling procedures. For instance, the
Task Force is charged with considering the:
(1) Definition and categorization of food biotechnology and production
processes. (2) Scientific literature on the subject, and the characterization of
information resources readily available to consumers. (3) Issues related to
domestic and international marketing of biotechnology foods such as the
handling, processing, manufacturing, distribution, labeling, and marketing of
these products. (4) Potential benefits and impacts to human health, the state's
economy, and the environment accruing from food biotechnology. (5) Existing
federal and state evaluation and oversight procedures.
315
Finally, the bill establishes a date, January 1, 2003, for the Task Force to
report the information discovered to the governor and legislature.1 6
This bill appears to be a sound scientific solution to managing consumer
fears, ensuring consumer safety, and respecting the findings of the FDA
all at the same time. Not all California bills have been designed with the
same focus however. Arguably, for that reason, they will not be
313. S.B. 2065, 2000 Reg. Sess. (Cal. 2000); S.B. 662, 2001-02 Reg. Sess. (Cal.
2001); see CAL. FOOD & AGRIC. CODE § 492 (Deering Supp. 2001). The legislative
findings start by saying that "[c]onsumers have an interest in being informed about the
benefits and potential quantifiable risks to their health from products they consume. This
information must be grounded in sound science, must use informative and effective
communications, and shall be consistent with other production technologies." S.B. 2065,
2000 Reg. Sess. § 1, art. 5, 491(a). The findings continue by recognizing the benefits
posed by new technologies and the need to balance those benefits with potential risks.
Id. § 1, art. 5, 491(b).
314. Id. § 1, art. 5, 491(c).
315. CAL. FOOD & AGRIC. CODE § 492(d).
316. Id. § 492(e).
[VOL 38: 893, 2001] Labeling Of Genetically Modified Foods
SAN DIEGO LAW REVIEW
accepted into law. Senate Bill 1514 for instance, which proposed to
establish a task force to inform parents of the use of genetically
engineered matter in food served in public schools, was vetoed by the317
governor of California in September 2000.- Senate Bill 1513, which
would have mandated "GM" labeling solely to protect the consumers
right to know, likewise failed passage.
318
California recently adopted a rice certification program to better
monitor the quality of rice and to identify various types of rice-a step
toward being able to distinguish between GM food products and non-
GM products. 319 The FDA suggested certification programs as a way to
ensure that voluntary labeling of rbST milk products were accurate,
3 0
and is therefore another example of a good way to focus state legislative
efforts.
VII. CONCLUSION
Modem genetic technologies offer great promise to increase the
world's food supply, enhance the nutritional value and appeal of foods,
reduce the number of toxins and pesticides in food products, and
establish sustainable environmental conditions.3'2 ' While GM foods
offer significant advantages over traditional foods, the actual difference
between GM products and non-GM products is slight.3'- After all, DNA
exists in all plant and animal material that humans consume. 32-1 While
DNA can have a drastic impact on the final product produced, its overall
effect on humans is not significantly apparent when considering the
317. S.B. 1514, 2000 Reg. Sess. (Cal. 2000). The intent of the bill was to inform
the public of issues relating to, among other things, the use of genetically engineered
materials in food. Id.
318. S.B. 1513,2000 Reg. Sess. (Cal. 2000).
319. CAL. FOOD & AGRIc. CODE §§ 55000-108 (Deering 1997 & Supp. 2001);
Assemb. B. 2622, 2000 Reg. Sess. (Cal. 2000). The regulation derived from the
"California Rice Certification Act of 2000." Id. The FDA offered the suggestion that
certification programs be adopted when dealing with rbST milk, so it is likely that such a
program would be consistent with guidelines from the FDA concerning GM food
products. See Interim Guidance on the Voluntary Labeling of Milk and Milk Products
from Cows that Have Not Been Treated with Recombinant Bovine Somatrotropin. 59
Fed. Reg. 6279, 6280 (Feb. 10, 1994).
320. Interim Guidance on the Voluntary Labeling of Milk and Milk Products from
Cows that Have Not Been Treated with Recombinant Bovine Somatrotropin, 59 Fed.
Reg. at 6280.
321. See supra text accompanying notes 20-21.
322. See supra text accompanying note I.
323. See generally Phipps, supra note 31.
microscale level on which DNA lies and to which modem GM
technologies function.
As with all new technologies and products, however, there is no way
to test the ultimate effect or outcome of the use of GM technologies on
society. This reality leads some to fear the advent of new technologies
all together and thus has created the debate over GM foods that troubles
the world at this time. The truth of the matter is that modern genetic
technologies may hold the key to improving food safety and do not offer
any more reason for fear than do traditional food products developed
using less efficient GM techniques.
Upon so finding, the FDA has taken reasonable measures to address
the GM food labeling debate. Based on the nonexistent risk of harm
apparent at this time from GM foods, the FDA was not only warranted in
rejecting mandatory labeling of such products, but arguably, was
required to do so. Without a verifiable safety risk to consumers, and
therefore an identifiable government interest, the FDA does not have the
power to trump the right of food suppliers to be free from compelled
communications. Instead, the FDA has chosen a policy of mandatory
review of GM products and voluntary labeling guidelines to protect
consumers from harm and from misleading advertising. This decision is
consistent with FFDCA regulation, with the FDA's prior treatment of
similar food products, and with legal precedent.
The decision to reject mandatory labeling for GM foods sheds new
light on the extent of the consumer's right to know. As has been
suggested in this Comment, the consumer's right to know is not absolute
and should be reviewed using a balancing test that takes into account the
competing rights of all parties involved. After review of the competing
interests, the limits on the right to know can be identified and the
findings of the FDA-that mandatory GM labeling is not appropriate-
can be validated.
In the case of GM foods, the consumer's right to food safety is not at3 24
issue because there is no identifiable safety risk at this time. The
consumers right to make informed food choices is also not implicated
because no nutritional or material difference between GM products and
their non-GM counterparts has been found to exist. The consumer's right to
324. Furthermore, the FDA has undertaken more appropriate steps to monitor the
safety of new GM products introduced to consumer shelves. See Premarket Notice
Concerning Bioengineered Foods, 66 Fed. Reg. 4706 (proposed Jan. 18, 2001) (to be
codified at 21 C.F.R. pts. 192 & 592); Draft Guidance for Industry: Voluntary Labeling
Indicating Whether Foods Have or Have Not Been Developed Using Bioengineering;
Availability, 66 Fed. Reg. 4839 (Jan. 18, 2001). Additional testing of GM products will
surely offer greater protection to consumer safety then a costly mandatory labeling
policy.
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freedom of religion may be a valid concern, but the government may not
apply religious principles in its regulations and therefore has limited
authority to affirmatively protect a consumers religious food preferences
without violating the First Amendment.
The consumer's right to know, in the case of GM foods, boils down to
a "desire" to be informed about GM foods and nothing more. The mere
desire to know has never been enough to mandate speech in the form of
food product labeling.3  Where no safety risk or other reasonably
necessary choice between food products exists, there is no significant
government interest to protect that can outweigh the rights of the food
supplier. Thus, due to the lack of safety risk and the fact that most
consumers are not sufficiently sophisticated at this time to understand
what GM really means, the FDA did not have the power to mandate
labeling under the FFDCA. The consumer's right to know is thus
limited to those cases where the consumer's health is at risk or where an
otherwise significant government interest exists that outweighs the rights
of the party that would be required to provide the consumer with
information. In the case of GM foods, the consumer's right to know
does not outweigh the food producer's right to freedom of commercial
speech and to trade between states. Thus, the consumer's right to know
is not sufficient to require mandatory labeling of GM foods.
Although mandatory labeling is not appropriate for GM foods,
voluntary labeling provides an alternate source of information for
consumers. As the FDA cannot mandate speech without a valid
governmental interest, likewise it cannot restrict speech without one. -26
Thus, the FDA cannot forbid labeling that addresses the GM issue. The
FDA must, however, regulate voluntary communications to assure that
consumers are not misinformed by the information pursuant to the
FFDCA.327 The FDA was therefore warranted in developing guidelines
for voluntary labeling that address the issue of possible misbranding and
false labeling.
As states consider alternative forms of regulation to address the
consumer's limited right to know, states will have to perform a similar
balancing test to develop regulations that will not be struck down under
the guise of First Amendment, federal preemption, or Commerce Clause
challenges. Labeling is not the only method to inform consumers of the
325. See discussion supra Parts IV.B.1, V.A.1.
326. Int'l Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 71-72 (2d Cir. 1996).
327. 21 U.S.C. § 343 (1994).
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realities of GM foods. States should consider other methods of
consumer education that are consistent with FDA guidelines and
findings if desiring to further protect the right to know in their own
localities.
In developing alternative forms of legislation, states should focus on
four specific goals when reviewing proposed legislative activity with
regard to GM foods: (1) adequate GM food product safety testing, (2)
consumer education designed to manage unreasonable consumer fears,
(3) encouraging global and interstate harmony by applying scientifically
valid principles, and (4) maintaining reasonable food costs and supplies.
When considering these objectives, states will likely foster a smooth
transition from the exaggerated consumer fears that exist today to a
consumer satisfaction with GM products. Consumer education
programs, development of rational voluntary labeling guidelines, and
methods to enforce such programs, in addition to further safety testing
procedures, are likely to be the best places for states to begin solving the
GM debate on a local level.
Globalized technological progress in food processing and supply
demands a rational regulatory system, like that rightly established and
enforced by the FDA. The reality is that GM foods should not be treated
any differently from traditionally modified food products when it comes
to labeling policies. Scientific studies and legal precedent, not creative
lobbying and economically driven consumer-fear programs, should
guide legislative bodies as they continue to address the issues that
surround GM food products. The health and safety of a growing human
population depend on it.
KELLY A. LEGGIO
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